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The quantitative measurement of structural alterations at the nanoscale level is important
for understanding the physical states of weakly disordered optical mediums such as cells/tissues.
Progress in certain diseases, such as cancer or abnormalities in the brain, is associated with the
nanoscale structural alterations at basic building blocks of the cells/tissues. Elastic light
scattering, especially at visible wavelengths range provides non-invasive ways to probe the
cells/tissues up to nanoscale level. Therefore, a mesoscopic physics-based open light scattering
technique with added finer focusing, partial wave spectroscopy (PWS), is developed to probe
nanoscale changes. Then, molecular-specific light localization technique, a close scattering
approach called inverse participation ratio (IPR) is proposed that is sensitive to nano to
microstructural cell/tissue alterations.
In this dissertation, we have introduced the further engineered PWS system with the finer
focus for precise volume scattering and molecular-specific light localization IPR techniques. As
an application of PWS, we first probe precise scattering volume in commercially available tissue
microarrays (TMA) tissue samples to standardize the existing cancer diagnostic methods by
distinguishing the cancer stages. We also apply the PWS technique to probe chemotherapy drug-

treated metastasizing cancer patients by xenografting prostate cancer cells using a mouse model
and identify drug-sensitive and drug-resistance treatment cases. On the other hand, as an
illustration of another mesoscopic physics-based molecular specific light localization technique,
Confocal-IPR, we study the effects of a probiotic on chronic alcoholic mice brains by targeting
the molecular specific alteration in glial cells, astrocytes and microglia, and chromatin of the
brain cells through staining with appropriate dyes/proteins. Using structural disorder of IPR as a
biomarker, the results show that probiotics in the presence of alcohol are beneficial and help
overall brain health. Finally, a TEM-IPR study was performed using nanoscale resolution TEM
imaging to support the optical IPR method by studying the anti-cancerous drug effect in ovarian
cancer cells. The result shows that we can quantitatively measure the effect of anti-cancerous
drugs in cancer treatment and the level of tumorigenicity far below the diffraction limit, and it
has a similar effect and supports the optical IPR method.
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CHAPTER I
INTRODUCTION: MESOSCOPIC PHYSICS BASED SPECTROSCOPIC SYSTEMS
Optical probing of tissue microarchitecture and cell nanoarchitecture could provide
tremendous information which is important for both diagnostic and therapeutic purposes
especially for deadly diseases like cancer. This is because the structural alterations are associated
with the progress of these diseases that result in the rearrangement of the basic macromolecules
in cells/tissues. With the progress of time, different biomedical optical techniques such as optical
coherence tomography (OCT), Mie scattering, fluorescence spectroscopy, diffusion
spectroscopy, Raman spectroscopy, elastic light scattering spectroscopy, etc. are in use and have
shown promising success to probe weakly disordered optical medium such as cells/tissue
architectural properties, to study/quantify abnormalities by probing the structural alterations [1–
10]. Among these techniques, elastic light scattering spectroscopy provides a non-invasive,
prompt, and cost-effective tool that is sensitive enough to probe the cells/tissues structures. The
photons scattered from any structure exhibits characteristics patterns based on scattering angle
and wavelength to provide the signature properties of scatter’s shape, size, density, refractive
index, etc. However, all these scattering methods: OCT, Mie scattering, fluorescence
spectroscopy, diffusion spectroscopy are based on the bulk spatial structural changes in
cells/tissues. Now, it is shown that probing the fluctuating part of the cells/tissues will provide
more sensitive information of the physical state of the system relative to the bulk changes.

1

Furthermore, the existing literature showed that the elastic back-scattering signal is
extensively sensitive to the refractive index fluctuations and their alterations [11]. Based on this
sensitivity of the back-scattering light, we can probe the tissue nano to microarchitectures in a
wide range of scales [3,5,12–14]. In the conventional elastic scattering experiments, before the
light exits tissue samples, it undergoes multiple scattering resulting in decreased sensitivity to
probe nanoscale cells/tissue architecture. At the same time, it is shown that progression of cancer
or any other abnormalities results in nano to submicron scale structural alterations in cells/tissues
due to the rearrangement of macromolecules [15–18]. However, the sensitivity of existing light
scattering techniques to probe refractive index fluctuations reduces significantly when the size of
the scattering structure falls below the scattering light wavelength (~500nm). The resolution of
conventional microscopy is ranged around 0.5m which is way below the size of
macromolecules [11]. On the other hand, confocal microscopy and single-molecule localization
microscopy which are sensitive up to 200nm to 10nm are highly dyed dependent. Likewise, we
can probe samples up to 1 A0 or a fraction of nm using a transmission electron microscope
(TEM) which requires complicated sample preparation and has huge and expensive setups. Since
the measurement of sub-wavelength refractive index fluctuation discloses the tremendous
information useful in diagnosis and therapies and has a significant interest in recent days. Here,
we apply mesoscopic light transport theory [19–21]. Using this, we can probe change in the
refractive index fluctuations of any length scale below the wavelength within the diffraction limit
if: (i) the object is weakly disordered and scattering medium, and (ii) analyze the multiple
interferences of 1D reflected signal within the object [15,16]. Therefore, we combine
mesoscopic physics with imaging techniques in order to increase the sensitivity of the existing
2

imaging technique and probe change in the refractive index fluctuations that happen at a
nanometer length scale.
In this dissertation, we have applied two different mesoscopic physics-based elastic
scattering techniques: (i) partial wave spectroscopy (PWS)-an open scattering approach and (ii)
inverse participation ratio (IPR)-a closed scattering approach. These techniques are capable of
probing changes in cells/tissue nano to microarchitecture and quantifies the statistical properties
of nanoscale refractive index fluctuations [15–17,22,23]. The recently developed and further
engineering added finer focusing PWS can probe precise scattering volume in tissue and
sensitive enough to detect the microarchitecture in tissue microarrays (TMA) and anti-cancerous
drug-treated xenografted tumors. And, molecular specific light localization technique, IPR, using
transmission electron microscopy (TEM) and confocal images enables us to detect of nano to
submicron scales structural alterations in cell and their components to quantify cancer, drugeffect in cancer treatment, and probiotic effect in the treatment of alcoholic’s brain.
In this introductory section, we will describe the instrumentation and mesoscopic
formulations for the PWS and IPR techniques. Then we will describe the samples that we have
probed using these techniques. Furthermore, to support the optical experiments, we have also
performed experiments using nanoscale sensitive TEM imaging, describe in short.
1.1

Partial wave spectroscopy (PWS) optical technique
Elastic light scattering spectroscopy is a very powerful and commonly used technique to

probe cells/tissue architecture [5,10]. The spatial variation of the concentration of intracellular
components in cells such as DNA, RNA, lipids, etc. due to diseases or cancer results in changes
in mass density fluctuations, in turn, spatial refractive index fluctuations. However, the size of
3

these macromolecular components falls below the diffraction limit of the existing optical
imaging technique which is 200nm. Therefore, in partial wave spectroscopy (PWS) we combine
mesoscopic physics with the imaging technique to probe the spatial refractive index fluctuations
in the weakly disordered medium, within the diffraction limit. PWS technique records 1D
backscattered signal in the far-field from cells/tissues and quantifies the refractive index
fluctuations at sub-diffraction length scale. According to the mesoscopic light transport
theory [19,20,24–26], the 1D reflected signal is the multiple references of light waves reflected
from reflective index fluctuations, which is non-self-averaging for all length scales in a weak
refractive index fluctuation [24–27]. And the importance of a non-self-averaging system is the
standard deviation and mean of a relative parameter increases with the increase in system size,
with full interference prominence. That means the reflected signal is sensitive to refractive index
fluctuations at any length scale even below the wavelength range [28–31]. This, therefore,
provides an opportunity to probe cell nanoarchitecture by characterizing 1D backscattered light
wave which is the most sensitive way. The experimental setup and theoretical details of the PWS
setup are explained below.
1.1.1

Partial wave spectroscopy (PWS) instrumentation
The developed finer focusing experimental setup for the partial wave spectroscopy

system in the Bionanophotonics laboratory in the Department of Physics and Astronomy at MSU
is as shown in fig. 1.1. A spatially low coherence broadband white light source (Xenon lamp,
150W, Newport) is used to illuminate thin samples using Kohler Illumination. The white light is
reflected by a silver coated mirror (2 inches, Thorlabs) towards the 4f combination of the
converging lenses (2 inches, f=30cm, Thorlabs) and gets collimated. The 4f combination of
4

Figure 1.1

The schematic diagram of the finer focusing PWS system.

Experimental layout of the Partial Wave Spectroscopy (PWS) setup with nanoscale sensitivity.
The green color represents broadband white light from the source and the red color after the
dichroic mirror is the backscattered signal. The collimated beams from the 4f combination of
lenses are focused on the sample using a highly sensitive motorized XYZ stage. Backscattered
signals are recorded in CCD passing through the liquid crystal tunable filter.
converging lenses along with the apertures (2inches, Newport) helps to minimize the diffraction
effect and preserve the high-frequency effect to enhances the sharpness of an image. The
collimated light is reflected by a right-angle prism (1 inch, Thorlabs) towards 40X objectives
(NA = 0.65, Newport) and focuses on the sample. A finer focusing is important to scatter the
precise volume of the sample. A highly sensitive 3D electronic motorized stage (X-Y axis 40nm
and Z-axis 100nm, Zebar Tech.) is used to focus the sample within the working distance of the
low numerical aperture objective. This high-resolution motorized 3D stage is considered
5

revolutionary to the microscopic setup for its extreme accuracy and finer focus. A finer focus is
essential for correctly defining the effective scattering volume/length of a sample. The 1D
backscattered signal from the sample is reflected towards the thick collecting lenses (3 inches,
Thorlabs) by a 50:50 dichroic mirror (1 inch, Thorlabs). The collected backscattered signal is
then recorded in a CCD camera (1460×1920, Retiga 3) after filtering the signal through a liquid
crystal tunable filter i.e. LCTF (KURIOS-WB1, Thorlabs) in the visible range of light. The
LCTF has a resolution of 1 nm in the wavelength range of 420 nm to 730 nm. Here, the CCD
camera and LCTF are coupled together with the LCTF controller in such a way that for every
wavelength signal filter by the LCTF in the visible range of light the backscattered signals are
recorded by the CCD camera. Finally, all 1D backscattered signals from the sample are recorded
in the CCD camera as a 3D data matrix I(x,y,) for the PWS analysis.
1.1.2

Theoretical model using the mesoscopic physics-based approach
The recorded backscattered intensity I(x,y,) are further analyzed to calculate the

fluctuating component, R(x,y,) of backscattered spectra arises from the interference of photons
reflected from refractive index fluctuations of a scattering object. Unlike the conventional light
scattering experiments where a scattering signal is formed by the interference of all waves
propagating within scattering particles in the far-field, in PWS backscattered spectrum analyzed
is formed by a subset of waves propagating in 1D. Low spatial coherence, high spectral
resolution, weak refractive index fluctuations, and small radius of curvature within the medium
are the conditions in which light propagates through a complex 3D structure and can be
approximated as a combination of several spatially independent parallel 1D channels, with less
mixing among the scattering channels. Here, the interference among different 1D channels is
6

negligible and can be further prevented by low coherence illumination. The flow chart of how
the PWS technique works is presented in the following figure.

Figure 1.2

The schematic of PWS data acquisition from thin samples.

Each pixel of the image is treated as an individual channel and the refractive index fluctuations
are recorded throughout the thickness of the sample (L). And hence, the degree of structural
disorder is quantified for every pixel of the image.
As mentioned, PWS expresses a 3D disordered medium into different parallel and
spatially independent 1D channels, acquiring the fluctuating components as R(k), where k is
obtained from the interference of light wave propagating in 1D backscattered channels (k=2π/λ).
For each pixel (x,y), the variance of the refractive index fluctuation (n) is computed as
sqrt(n2). And k is computed from the intensity vs wavelength measurement of I(k) at each pixel
(x,y). From the signal I(k) the high-frequency noise is filtered out using a low order Butterworth

7

Figure 1.3

The 3D data acquired for PWS analysis.

Scanning the wavelength in the visible range of light from 430 to 720nm 3D spectroscopic data
cube is recorded where XY represents the frame of the image(camera) and Z is the wavelength in
the visible range using PWS microscopy.
filter to obtained R(k). Further, variation in light source spectrum, instrumental artifact, sample
roughness, etc. are filtered-out fitting with a low order polynomial Ip(k) to I(k). Finally, the
fluctuating part of the reflection coefficient is obtained as R(k)= I(k)- Ip(k). Now the question is
how the fluctuating component R(k) is related to the properties of samples like average refractive
index (n0), sample thickness or length of light penetration in the medium (L), the variance, and
the correlation length of the refractive index fluctuation (<n2> and lc).
In a weakly disorder scattering medium i.e. R<<1, for every length scale the probability
density distribution of R follows a lognormal distribution. Thus, for length L the ensemble
average of R distribution over the ensemble of 1D independent parallel disorder channels is
given by:
1
⟨𝑅⟩ = [exp (4𝑘 2 𝐿𝑑 𝐿⁄ 2 ) − 1]
𝑛0
2

8

(1.1)

Since average refractive index for biological cells/tissues is n0 = 1.38 we assume that 4k2LdL/n02
<< 1, in the above equation, therefore can be approximated as:
1 4𝑘 2 𝐿𝑑 𝐿 2𝑘 2 𝐿𝑑 𝐿
⟨𝑅⟩  (
)
,
2
𝑛02
𝑛02

(1.2)

In a regime with the valid 1D independent channel, R(k) can be characterized using 1D
mesoscopic light transport theory [19–21], and the root mean square average of R(k) can be
written as:
(1.3)

⟨𝑅⟩ = 𝐿𝜉 −1 ,
Where 𝜉 −1 is the scattering coefficient of the 1D channel simplified for klc<< 1: 𝜉 −1 
2𝑘 2 𝐿𝑑 𝐿/𝑛02 with Ld = <n2> lc. Therefore,
𝜉

−1

2𝑘 2 ⟨𝛥𝑛2 ⟩𝑙𝑐
(
).
𝑛02

(1.4)

To eliminate L, and only use intrinsic properties of the sample, we introduce an
autocorrelation function ⟨𝐶(𝛥𝑘)⟩:
⟨𝑅(𝑘)𝑅(𝑘 + 𝛥𝑘)⟩
,
⟨𝑅(𝑘)𝑅(𝑘)⟩
Based on mesoscopic theory, ⟨𝐶(𝛥𝑘)⟩ can be expanded as [19]:
⟨𝐶(𝛥𝑘)⟩ =

⟨𝐶(𝛥𝑘)⟩  𝑒𝑥𝑝(−(𝛥𝑘)2 𝑓(𝐿𝑑 ) 𝐿).

(1.5)

(1.6)

Where 𝑓(𝐿𝑑 ) is a slowly varying function for realistic values of the disorder strength which may
be considered as constant for a range of k, and  is a constant with a unit of length. Thus,
𝑙𝑛(⟨𝐶(𝛥𝑘)⟩) = −(𝛥𝑘)2 𝑓(𝐿𝑑 )𝛼𝐿; 𝐿 = −

1 𝑙𝑛(⟨𝑐(𝛥𝑘)⟩)
.
𝛼𝑓(𝐿𝑑 ) (𝛥𝑘)2

Using the above equation, the mean reflectance fluctuation can be obtained as:
9

(1.7)

2𝑘 2 𝐿𝑑 𝑙𝑛(⟨𝑐(𝛥𝑘)⟩)
⟨𝑅⟩  −
.
𝑛02 𝛼𝑓(𝐿𝑑 )(𝛥𝑘)2

(1.8)

Hence, for slowly varying functions knowing ⟨𝑅⟩ and 𝐶⟨𝛥𝑘⟩ for each channel in the sample one
can calculate disorder strength (𝐿𝑑 ) as:
𝐿𝑑 =

(𝛥𝑘)2
𝐵𝑛02 ⟨𝑅⟩
.
2𝑘 2 − 𝑙𝑛(⟨𝐶(𝛥𝑘)⟩

(1.9)

Where B is a calibration constant determined experimentally, k is the wavenumber (k=2/)and
(𝛥𝑘)2 /𝑙𝑛⟨𝐶(𝛥𝑘)⟩ is obtained by performing a linear fit of 𝑙𝑛⟨𝐶(𝛥𝑘)⟩ vs (𝛥𝑘)2 .
For the Gaussian color noise of the refractive index at position r and r’, then spatial
correlation is defined as: <dn(r)dn’(r’)> = dn2 exp(-|r-r’|/lc), it can be shown that Ld=<𝛥n2>lc.
Thus, the disorder strength quantifies the variability of the local density of intracellular material
within the samples, and hence the average and standard deviation of the Ld is calculated to
characterize the structural abnormalities of the system.
1.1.3

Applications of the finer focusing PWS technique on cancer tissue samples
As applications of the developed nanoscale sensitive PWS system, we first quantify the

nanoscale changes in mass density or refractive index fluctuations using commercially available
TMA tissue samples in progressive cancer. Then we employ this sensitive technique to probe the
refractive index fluctuations in 3D tumor structure grown from 2D drug-sensitive and drugresistant prostate cancer cells using a xenograft model, to differentiate the difference in structural
changes in 2D and 3D growths. Following are the details.
In chapter II, we use the developed highly sensitive PWS technique to quantify the
nanoscale refractive index fluctuations using commercially available paraffin-embedded tissue
microarrays (TMA) samples with the goal to standardized early to late cancer stages detection
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and possible application in the future to study drug effect in cancer treatment. Recently the use of
these scientific TMA tissue samples has gained research interest in diagnosing different diseases
and drug-effect in treatment since they allow high throughput analysis and are easily accessible.
Fractal dimension study of TMA sample shows that fractal dimension increases with the increase
in cancer stages. Also, cancer is an epidemic worldwide, early, and accurate detection, as well as
the study of drug effects in cancer treatment, are always in demand. Therefore, in this study, we
mainly focused on deadly cancer tissue samples such as pancreatic, prostate, breast, and colon
cancer TMAs containing multiple cores of different stages for each cancer. These are analyzed
using the PWS technique and the degree of disorder strengths Ld were quantified and
distinguished the stages of cancer successfully. The promising application of the TMA-PWS
technique will be explored in detail.
In chapter III, we are mainly interested to study the structural properties of the tumor
tissues that are developed from drug-sensitive and drug-resistive prostate cancer cells inside the
body using the PWS technique. Other than cancer detection, the effects of cancer drug treatment
are also an important field in cancer study. One of the questions addressed here is to see the
difference between the 2D and 3D growth structures in cancerous cells for detection/estimation
of cancer by cell/tissue cultures. At this point, a PWS study of the drug-sensitive and drugresistive prostate cancer cell lines 2D model showed that drug-resistive cancer cells have higher
structural disorders relative to drug-sensitive cancer cells, at the single-cell level. In this chapter,
using a further engineered PWS, we characterize tumor 3D structure developed from the
docetaxel chemotherapy drug-sensitive and drug-resistant different prostate cancer cells by a
xenografted model, to study the structural properties of these cancer single cells grown in 2D
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slides to 3D tissues in xenografting technique. The result obtained is important and hence, the
potential applications of the technique to access chemo drug effectiveness in the treatment of
human cancer patients will be discussed.
1.2

Inverse participation ratio (IPR) photonics technique
Light localization arises due to the interference of light waves within the optical

disordered medium. In condensed matter physics, the light localization method which we defined
as the inverse participation ratio (IPR) technique has been well studied for characterizing the
degree of disorder of homogeneous and heterogeneous media in a single parameter [32–34].
Further, quantification of light localization in weakly disordered optical disorder mediums such
as polymers, thin dielectric films, cells, and tissues, etc. is a major interest of research to
characterize the degree of structural disorder of that medium. The characterization of these
optical disordered mediums using standard methods is more complicated if the system involves
spatial heterogeneity involving many kinds of spatial correlation decay length scales within the
sample like cells/tissues [35,36]. In the present day, significant research has been performed in
quantifying structural disorders of cells/tissues by analyzing the light transportation and
localization properties [15–17,22,23,37]. This research has shown that analysis of light
localization properties of cells/tissue is a useful technique to understand the intramolecular
tumorigenicity levels, by probing their structural disorder. The light localization technique was
explored to study nano to submicron scale structural disorder in cells/tissues with a potential
application in cancer diagnostics [22]. Consequently, this novel approach of using mesoscopic
physics-based optical localization analysis [28,32,33], to understand disease processes in
cells/tissues has created a new avenue in medical diagnostic technologies. In ref [22], it is shown
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that the degree of structural disorder in heterogeneous biological samples can be quantified as a
single mixed parameter via IPR analysis of the light wavefunctions of these systems. In a weakly
disorder system, the degree of structural disorder relates to the mass density or refractive index
fluctuation which is linearly proportional to the IPR value of the system [32,33]. In this
technique, transmission electron microscopy (TEM) or confocal fluorescence microscopy
micrographs are used to construct optical lattices from the sample which represents 2D refractive
index map corresponding to the spatial mass density distribution of specific molecule within the
cell; subsequently light localization properties were analyzed [22,23,38]. Last few decades the
disorder analysis of the optical media has been well studied using light localization
properties [28–30,32,33,39]. In a closed disordered optical medium, the light wave
eigenfunctions are localized due to the multiple interference effects within the disordered
sample. The main length scale associated with the problem, in IPR technique is the localization
length or the scattering mean free path, which is related to the physical properties of the system,
refractive index fluctuations and its correlation. Light localization effect is strong in 1D and 2D
systems and the average IPR value of uniform lattice in 2D is universal number ~2.5, but the
value increases with an increase in degree of disorder of the lattices [32].
1.2.1

Confocal microscopy imaging
Confocal laser scanning microscopy is a powerful optical imaging technique that offers

significant advantages over conventional microscopy to view the biological samples with high
optical resolution and contrast of a micrograph [40–42]. In laser scanning microscopy the
specimen is scanned by the diffraction-limited spot of laser and the light reflected by the in-focus
illuminated volume element of the specimen is focused onto a photoreceptor. It uses a spatial
13

pinhole to block out-of-focus light to form an image, on the image plane. Confocal microscopy
enables capturing of multiple 2D backscattered photons at different depths of a sample and
constructs a 3D structure. Therefore, the ability to control the depth of field, eliminate or reduce
information from the focal plane, and collect serial optical sections of thick samples has
enhanced advantages in optical microscopy. The fluorescence emitted by the molecule from a
small volume around the excitation center is collected by the objective into the photodetector
using a spatial pinhole. The schematic of how the confocal microscopy work is presented in the
following Fig. 1.4.
As shown in Fig 1.4, confocal microscopy consists of the laser source, scanning mirror or
dichroic mirror, objective lens, pinholes, and a detector. The backscattered signals from the
samples are collected by the objectives and recorded into a detector through a confocal pinhole
that blocks the out-of-focus light. Thus, confocal pinhole rejects out-of-focus light resulting in
high optical resolution and contrast image and have made confocal microscope a powerful
technique in obtaining 3D optical resolution.
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Figure 1.4

A schematic ray diagram of confocal microscopy.

Schematic ray diagram based on the principle of recently developed laser scanning confocal
microscopy. In confocal imaging, samples are treated with different dyes/proteins targeting
different cells/components of the cells using different excitation sources.
1.2.2

Transmission electron microscopy (TEM) imaging
Transmission electron microscopy uses de Broglie wavelength of electrons from a

micrograph that has a significantly higher resolution than any existing fluorescence microscopy.
In TEM microscopy high-energy electrons (80-200kev) are transmitted through electron
transparent samples (~100nm thickness) and probe up to ~1nm to identify the nanoscale
architectural alterations inside the cells due to progressive cancer or any other abnormalities.
That means a beam of the electron is transmitted through the ultrathin specimen to form a TEM
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image. The image is magnified and focused onto an imaging device known as a fluorescent
screen. Hence, TEM and scanning TEM techniques can provide imaging, diffraction, and
spectroscopic information with an atomic or sub-nanometer spatial resolution and contribute a
major analytical tool in the physical, biological, and chemical sciences [43–45].
The schematic diagram for the TEM micrograph formation is shown in Fig. 1.5. In brief,
TEM components include electron source, condenser lenses, objective lens system, intermediate
or projector lenses, and a detector. They produced high energy and coherence electron source
necessary for diffraction pattern is passed through condenser lenses which control the spot size
and illumination area of the specimen. An objective lens system is used to images the specimen
and intermediate or projector lenses change the modes from diffraction to imaging. Finally,
highly sensitive and low quantum efficiency detectors of various configurations are used to
collect the secondary signals produced by the high-energy electron beam.
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Figure 1.5

A schematic ray diagram of transmission electron microscopy (TEM).

Schematic ray diagram of TEM in image mode where electron beam passes through the thin
sample to produce micrograph in fluorescent screen. Therefore, a TEM micrograph can represent
the mass density of the thin cell sample.
1.2.3

The theoretical model for analysis of confocal/TEM micrograph using mesoscopic
light localization approach
The optical lattices of cells/tissues are constructed using TEM or Confocal micrograph to

study the molecular specific light localization properties. It is found that optical refractive index
n(x,y) is linearly proportional to the local density ρ(x,y) of intercellular macromolecules such as
DNA, RNA, lipids, or protein present in cells. The refractive index of a cell can be expressed as
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n(x,y)=n0 + dn(x,y), where n0 is the average and dn(x,y) is the fluctuation of refractive index at
(x,y) [22,23]. In the case of the thin sample, a voxel of area dxdy the transmission or scattered
intensity: I(x,y) = I0exp(-dz/z0); or I(x,y) I0(1-dz/z0)= I0 - I0d(z), where  is a constant
depends on the mass of voxel. That means, image intensity at any voxel point (x,y) for a thin
sample dxdy defined as I(x,y) given by I(x,y) = I0+ dI(x,y), where I0 is the average pixel intensity
and dI(x,y) is the fluctuation part of the pixel intensity. The fluctuation of intensity dI(x,y) is less
than the average intensity I0: I0=<I(x,y)>(x,y) and dI(x,y)=I(x,y) - <I(x,y)>(x,y). Similarly, the
fluctuation of refractive index dn(x,y) is less than the average refractive index n0.
We assume that image intensity is linearly proportional to the total mass present in the
thin cell voxel. Therefore, it is observed that (i) image intensity I(x,y) is linearly proportional to
the mass density of the voxel M(x,y), and (ii) the refractive index of the voxel n(x,y) is
proportional to the mass density M(x,y), then we can write:
𝐼(𝑥, 𝑦) ∝ 𝑀(𝑥, 𝑦) ∝ 𝑛(𝑥, 𝑦),

(1.10)

𝐼0 + 𝑑𝐼(𝑥, 𝑦) ∝ 𝑀0 + 𝑑𝑀(𝑥, 𝑦) ∝ 𝑛0 + 𝑑𝑛(𝑥, 𝑦).

(1.11)

Consequently, it can be shown that the effective(average) optical potential or optical
lattice, εi, for the voxel around the point (x,y) is
𝜀𝑖 ∝

𝑑𝑛(𝑥, 𝑦) 𝑑𝐼(𝑥, 𝑦)
=
.
𝑛0
𝐼0

(1.12)

The schematic of the disorder optical lattices of size LL of TEM/Confocal image where
each dot in the optical lattice is determined from the pixel intensity values in recorded images as
shown in the figure below.
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Figure 1.6

Construction of a disorder optical lattices from TEM/Confocal micrograph.

A typical example of z-stack confocal micrographs from which one micrograph is selected and
optical/refractive lattices are constructed for a small close region.
Tight-binding model: To quantify the disorder properties of TEM or Confocal images,
Anderson disorder tight-binding model (TBM) calculation was employed. The TBM is a good
model for describing single-optical states of the system of any geometry and disorder [28–30],
where the Hamiltonian is defined as:
𝐻 = ∑𝑖|𝑖 >< 𝑖| + 𝑡 ∑⟨𝑖𝑗⟩ (|𝑖 >< 𝑗| + |𝑗 >< 𝑖|) ,

(1.13)

where |i> and |j> are the optical wave function or eigenvectors at i-th and j-th lattice sites, <ij>
indicates the nearest neighbors, εi(x,y) or simply εi is the i-th lattice site optical potential energy
and t is the overlap integral between sites i and j. The eigenfunctions (Ei’s) can be obtained by
diagonalizing above the Hamiltonian. For a sample length L in the image, we have L×L sample
area. The average IPR at sample length L is calculated where L=NL×dx (dx=dy). Since there are
N=NL×NL numbers of lattice points, thus, there will be N eigenvalues and the same number of
eigenvectors. Now substituting the value of εi in Hamiltonian and solving for average IPR value
of the sample of length L defined as [22,23,32,33,46,47]:
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𝑁

𝐿 𝐿
1
< 𝐼𝑃𝑅(𝐿) >𝐿×𝐿 = ∑ ∫ ∫ 𝐸𝑖4 (𝑥, 𝑦)𝑑𝑥𝑑𝑦,
𝑁
0 0

(1.15)

𝑖=1

Where Ei is the i-th eigenfunction of the above Hamiltonian equation of optical lattices of size
L×L, and N is the total number of potential points on the refractive index matrix (i.e.,
N=(L/dx)2). That means if there is LL sample length or N number of image pixels, this will
provide one pixel of the IPR image of length L, as <IPR(L)>LL.
It has been shown that the ensemble average of IPR value i.e. averaged of similar type of
cells: <<IPR(L)>>=<<IPR(L)>L×L> or (<IPR(L)>, is proportional to the degree of structural
disorder Ld=dn×lc, where dn is the std of all n(x,y) point of cell samples/ensemble and lc is the
spatial correlation decay length of the average n(x,y) over the sample [22,23]. Thus,
⟨⟨𝐼𝑃𝑅(𝐿)⟩⟩ = ⟨⟨𝐼𝑃𝑅(𝐿)⟩𝐿×𝐿 ⟩𝑐𝑒𝑙𝑙 ∼ 𝐿𝑑 = 𝑑𝑛 × 𝑙𝑐 ,

(1.16)

𝜎(⟨𝐼𝑃𝑅(𝐿)⟩) = 𝜎(⟨𝐼𝑃𝑅(𝐿)⟩𝐿×𝐿 )𝑐𝑒𝑙𝑙 ∼ 𝐿𝑑 = 𝑑𝑛 × 𝑙𝑐 .

(1.17)

The < 𝐼𝑃𝑅(𝐿) >𝐿×𝐿 is the average value of one IPR pixel of length (L) constructed from
the L×L area of the TEM or Confocal image. After this, statistical analysis involves calculating
the average and standard deviation of the disorder strength of IPR values, i.e. Ld values over the
cell for the length of a given sample. Using this structural disorder strength <<IPR(L)>> or
(<IPR(L)>) or Ld as a biomarker, we quantify the nanoscale structural abnormalities in
cells/tissues due to cancer or any other abnormalities. A typical schematic of the steps involved
in the quantification of structural disorder to study the drug effect in cancer treatment using a
TEM micrograph is shown in figure 1.7.
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Figure 1.7

Schematic flowchart for calculating and comparing the <IPR> using TEM images.

In summary, the main steps involved in the calculation of <IPR> using a TEM micrograph are
presented in the schematic flowchart.
1.2.4

Steps involved in the IPR calculation
In brief, we want to summarize the steps involved in the calculation of IPR explained in

above Section 1.2.3. Fig. 1.7 roughly shows the steps involved in the calculation of the average
or std of IPR and IPR images from the confocal or TEM micrograph. However, the steps
involved in the IPR calculation can help you better understand how we quantify disorder strength
(Ld) using the IPR technique and confocal or TEM micrograph:
Step I: Confocal or TEM micrographs are collected from the cells/tissues.
Step II: Using the pixel intensity values of the micrographs, a pixel intensity was obtained in the
form of a matrix as: I(x,y) = <I0> + dI(x,y).
Step III: Based on pixel intensity matrix of micrograph optical refractive index lattices/matrix is
obtained which correspond to the one-to-one micrograph pixel intensity expressed as: dn(x,y)/n0

∝ dn(x,y)/<I0>. And hence the optical lattice system of the micrograph is obtained such that
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every point in the optical lattice is defined as optical potential represented by ε(x,y) = dn(x,y)/ n0.
Now the micrograph intensities are replaced by the optical potential matrix which in turn
represents the refractive index or mass density fluctuation of the sample. Hence the optical lattice
depicts the refractive index variation of the 2D plane to calculate the disorder strength inside the
sample.
Step IV: Now if 2D lattices have M×M pixels with the pixel size a, then the total pixel size of
the 2D micrograph is Ma×Ma. For instance, we choose a small sample size L×L, with m×m
optical lattice points with L = ma (M>m). Applying Anderson Tight Binding Model on this
sample size using optical lattice we will calculate the eigenfunction Ei of the small close system.
Step V: Once the eigenfunction of the close system L×L is obtained we calculate the <IPR>L×L
using the equation (1.15). Here it represents the unit block or the IPR pixel of the IPR image.
That means we repeat this process throughout the micrograph and the distribution of <IPR>L×L is
obtained, which is represented in the IPR image. For Ma×Ma confocal 2D micrograph Ma/m ×
Ma/m IPR pixels are constructed.
Lastly, the ensembled average or standard deviation of <IPR>L×L is obtained from
<IPR> distribution of IPR image at L×L by averaging or calculating std of all micrographs of
the cells/tissues for the particular case study as <IPR(L)>= <<IPR>L×L > or σ(<IPR>) =
σ(<IPR>L×L).
1.2.5

Applications of confocal-IPR and TEM-IPR techniques
IPR is a very powerful technique to quantify the molecular-specific disorder present in

the weakly disorder optical medium based on the light localization on the closed system and has
numerous applications. Mainly in this dissertation, we will apply IPR techniques combined with
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confocal and TEM imaging to quantify nano to submicron scale mass density or refractive index
fluctuations to study probiotic effects in chronic alcoholic brain cells and anti-cancerous drug
effect in ovarian cancer cells using a mouse model.
In chapter IV, using a confocal-IPR technique we will quantify the molecular specific
structural alteration in glial cells and chromatin of the alcoholic brain cells and study the
probiotic, Lactobacillus Plantarum treatment on chronic alcoholic brain cells/tissues at the
submicron level. Previously, confocal imaging using IPR has shown tremendous success in
distinguishing cancer stages now we want to explore its applications in determining brain
abnormalities. Based on the close scattering technique, we probe overexpression of astrocyte and
microglial cells, and chromatin structures of brain cells, and quantify the molecular-specific
overexpression by staining the cells with appropriate dye/proteins and calculating the degree of
spatial molecular mass density structural disorder (Ld). Our technique has successfully detected
the effect of the probiotic in alcoholic brain cells and components. The potential application of
this novel approach to diagnosing the alcohol effect and probiotic treatment in the alcoholic brain
is explored.
In chapter V, combing the IPR technique with TEM images we quantify the efficacy of
the anti-cancerous drug treatment in ovarian cancer treatment using a mouse model. Here, we
also want to know how the IPR technique is useful with nanoscale resolution, especially in
cancerous cells. The TEM imaging on thin cell, sections are performed to obtain their nanoscale
structures up to 1 nm. Therefore, using TEM-IPR we can probe up to a few nanometers to
quantify the structural alterations of tumorigenic cells and anti-cancerous drug-treated
tumorigenic ovarian cancer cells which are initially effective at the nanoscale level. Results are
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interesting and support that the effect of anti-cancerous drugs in cancer treatment can be
quantified by using the degree of nanoscale fluctuations of the cells via TEM imaging. Potential
applications of the TEM-IPR technique for cancer treatment are also discussed.
Lastly, in chapter VI, conclusions of the close and open scattering spectroscopic
techniques PWS and IPR, respectively are presented and their near-future applications are
explored in detail.
1.2.6

Advantages of PWS and IPR techniques over the existing other spectroscopic
scattering technique
Despite the tremendous achievement in the development of different biomedical optical

techniques such as optical coherence tomography (OCT), fluorescence spectroscopy, diffusion
spectroscopy, coherence enhanced backscattering, etc. [1–10,48] the optical sensing of the
nanoscale structure remains an open problem due to the fundamental principles of diffractionlimited resolution. These techniques are mainly based on the change in the scattering signal
when the bulk properties of a sample are changed (n(x)=n0+dn(x), <n(x)>=n0). In the case of
cancer detection, these methods are useful in the later stages of cancer when there is a prominent
change in the bulk properties. But it is recently proven that fluctuations (dn(x)) part of the
refractive index are more sensitive and vital information about the system even when the bulk
properties do not change. By using nonlinear techniques, spatial-frequency evanescent waves,
metamaterial-based lenses, and grating assisted tomography have enhanced a resolving power
beyond the diffraction of a light [49,50]; however, the super-resolution is confined to the
transverse plane which limits its ability to characterize sub-diffraction structure in 3D [51,52]
and allows only the spatial distribution of particular molecular species. This demands the
exploration of non-invasive, label-free, cost-effective, and elastic scattering spectroscopic
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microscopy techniques to characterize the endogenous properties of the medium based on the
spectral content of diffraction-limited microscopic images such as PWS. The PWS and IPR
technique is pioneering in probing the fluctuation part of the RI to probe the physical state of
cells or tissues. The theory behind the PWS technique involves strong assumptions that 1D
backscattered signals are sensitive to refractive index fluctuations at any length scale including
far below the wavelength range [11]. Using both open (PWS) and close (IPR) scattering we
probe the particular structure in a weakly disordered medium in terms of the refractive index
fluctuations where 1D scattered signals are sensitive to any length scale. The important aspect of
these mesoscopic physics-based PWS and IPR techniques is a quantification of the Ld parameter
which linearly depends on lc for klc< 1. Thus, in principle, there is no limitation on the minimum
correlation length that can be assessed by the means of spectral analysis of 1D propagating
photon. In practice, the sensitivity of lc is limited by the signal-to-noise ratio and other technical
parameters. That means the sensitivity of these spectroscopic techniques is not limited by
fundamental physical limits. Besides this advantage, PWS is simple, cost-effective, fast, and
portable, on the other hand, the IPR technique is simple, effective, and robust to probe inner
fluctuations at the nano to submicron level using confocal and TEM imaging.
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CHAPTER II
OPTICAL DETECTION OF CANCER STAGES VIA PWS USING TISSUE MICROARRAYS
(TMA) SAMPLES
This chapter is adapted from the author’s published article with copyright permission
from the publishers. Ref [61] P.Adhikari, F. Alharthi, and P. Pradhan, “Partial Wave
Spectroscopy Detection of Cancer Stages using Tissue Microarrays (TMA) Samples,” in
Frontiers in Optics + Laser Science APS/DLS (2019), Paper JW4A.89, OSA 2019; and
Ref [94] P. Adhikari, and P. Pradhan, “Optical detection of cancer stages via partial wave
spectroscopy using tissue microarrays (TMA) samples”. arXive 2012.14194, 2020.
The developed finer focusing added mesoscopic physics-based imaging technique, PWS
can probe the precise scattering volume in cells/tissue to detect changes in refractive index
fluctuation with the progression of cancer. Here, we employ this highly sensitive PWS technique
to quantify the nanoscale refractive index fluctuations using commercially available paraffinembedded TMA samples with the goal of the standardized early and accurate detection of stages
of different cancers. The uses of scientific TMA samples have gained research interest in
diagnosing different diseases and drug treatment since they are commercially accessible. Mainly,
deadly cancer such as pancreatic, prostate, breast, and colon cancer TMAs containing multiple
cores of different stages for each cancer are analyzed using the PWS technique and the degree of
disorder strength (Ld) was quantified. The potential application of the developed TMA-PWS
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technique to enhance and standardize early and accurate cancer diagnosis modalities are
discussed.
2.1

Introduction
The optical detection of structural changes in biopsy samples due to progressive cancer

has achieved tremendous success in detecting the stages of cancer when developed into a
tumor [53]. The standard pathological method of detection of cancer stages includes
microscopic examination of the morphological changes using stained biopsy samples. However,
due to the diffraction-limited resolution of conventional microscopy, the structural alterations in
healthy tissue before the development of a tumor or early stages are still a mystery. These
structural alterations of healthy cells/tissue are due to the rearranging of macromolecules such as
DNA, RNA, lipids, etc. whose size ranges from 100-200 nm. It is recognized that genetic and
epigenetic alterations occur not only at the neoplastic focus but more diffusely in the field of
cancerization. The abnormalities are present in the tissue surrounding the cancerous region or
transformed cell primary tumor due to field cancerization [54,55], which are initially at the
nanoscale level before tumor formation and migration. This effect is observed in almost every
type of cancer that is diagnosed in the later stages with less survival rates. Therefore, a highly
sensitive optical method to detect such structural abnormalities before the development of a
tumor for all cancer is paramount for decreasing lethality [56]. With the progress of time,
several microscopic imaging techniques were employed, and regardless of their drawbacks,
significant success was achieved [57]. Unfortunately, most of these methods are still not
sensitive enough to probe the nanoscale structural changes. In light of this scenario, the versatile
approach of using recently developed PWS to probe change in the refractive index fluctuations in
commercially available tissue microarray (TMA) samples could standardize the cancer
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diagnostic modalities. The recently developed finer focusing PWS technique is sensitive enough
to probe nanoscale refractive index fluctuation in paraffin-embedded TMA samples. The PWS
combines interdisciplinary approaches of mesoscopic physics and optical imaging techniques to
quantify the degree of disorder strength (Ld) based on the change in refractive index fluctuations
within the cells/tissue [15–17,58]. The backscattered signal at any point within a weakly
disordered medium contains the spectral fluctuations which are proportional to the local density
of macromolecules or refractive index fluctuations, in fact, independent of chemical
composition. Thus, once the refractive index fluctuations of the medium are known, the spatial
variations of macromolecular density can be measured using the disorder strength (Ld) measure
as Ld =<dn2>lc, where <dn2> is the square of rms and lc is the correlation length of the refractive
index fluctuations [16,17]. This potential biomarker, the Ld parameter has shown tremendous
success in distinguishing stages of cancer, drug-effect in cancer treatment, and quantifying any
other type of abnormalities in the brain [17,58–61]. In addition to this, structural alterations in
biological cells/tissue due to cancer or any other abnormalities are quantified using mesoscopic
physics-based molecular specific light localization technique in terms of the degree of disorder
strength [23,38,62–64].
With the availability of such a powerful approach to quantify the nanoscale structural
alterations in cancerous tissue, the next challenge was in the use of an almost identical tissue
sample that allows high-throughput analysis to standardize diagnostic techniques. For this, the
recently developed commercially available TMAs have been used which significantly facilitate
and accelerates tissue analyses using a highly sensitive PWS technique. The TMA is a scientific
form of condensed histopathology where the tissues are kept in a single glass slide to provide a
miniature multiplex platform for the analysis of ~10 to ~200 tissue samples [65]. Multiple cores
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of paraffin-embedded tissue in a TMA allow high-throughput assessment of macromolecules in
PWS analysis that standardize the diagnostic technique reducing the variability seen on the assay
of individual samples. This uniformity of assay has reduced the drawbacks in specimen handling
and their impact on data acquisition [66]. Besides these facts, TMA samples are easily
accessible to perform any scientific experiments which require more than one similar sample.
Also, we believe the use of the PWS technique in the TMA sample could be a new direction to
explore to study the drug effect in cancer or any other abnormalities that are in demand. This can
be noted that we want to probe change in RI fluctuations in tissue samples that are embedded in
paraffin.
In this chapter, we will analyze four different deadly cancer TMA samples: pancreatic,
breast, colon, and prostate, and generalize the efficacy of developed finer focusing PWS to
detect the cancer stages. Cancer is a common disease and with no surprise, these four different
cancers are the major cause of death in the U.S. Because of lethality, prevalence, and almost no
prominent physical change or symptoms until the later stages. We focus on studying the
nanoscale structural changes in these cancerous tissues by quantifying the degree of structural
disorder (Ld) as a potential biomarker. In this sense, we explored the potential possibilities of the
PWS technique in TMAs for the early stage of cancer detection.
2.2
2.2.1

Methods
Experimental development of the PWS
The engineered finer focusing PWS system used to probe the precise scattering volume

developed in the Bionanophonics laboratory is as shown in Fig. 2.1. The experimental details of
the PWS setup are presented in Chapter I Section 1.1.2 [58–60,67]. We will present a 3D view of
the PWS system presented in Chapter I. In brief, the developed PWS system consists of a low
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coherence broadband stable white light source Xenon lamp which is reflected toward the 4f
combination of lenses by a mirror and gets collimated. Collimated beams are reflected towards
the objectives and focus on the sample with the help of a highly sensitive XYZ motorized
scanning stage (XY-axis 40nm and Z-axis 100nm). Then, the backscattered signal from the
sample is directed towards the CCD camera through the liquid crystal tunable filter (LCTF) with
the help of a dichroic mirror. Here, LCTF is coupled with a CCD camera in a way that for every
wavelength in the visible range, images are recorded in the CCD camera for the PWS analysis.

Figure 2.1

The 3D schematic of further engineered finer focusing PWS system.

The schematic 3D layout of the finer focusing partial wave spectroscopy (PWS) system was
developed in the Bionanophotonic laboratory. The collimated beam (green color) from the
broadband stable white light source (Xe lamp) is focused on the sample and the backscattered
signal (red color) from the sample is collected using the CCD camera for PWS analysis.
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2.2.2

Calculation of the disorder strength (Ld)
In the PWS technique, the backscattered spectrum of a weakly disorder medium is

recorded in the visible range of light to quantify the degree of disorder strength (Ld) based on the
refractive index fluctuations (n) within the cells/tissue. It is shown that at each pixel position
(x,y) within the cell, the refractive index (n) is proportional to the local mass density and
practically independent of chemical composition at that point. Therefore, the spatial variation of
macromolecular mass density at every pixel position can be expressed in terms of refractive
index fluctuations, assuming that these random fluctuations are within a correlation length (lc).
The recorded backscattered spectrum R(x, y; ), is the interference between the intercellular
volume scattering and reflection from the surface of the sample. That means the measured
spectra from each pixel of an image is a 1D weakly disordered medium that acts as a subset of
the scattered waves.
The step-wise quantification of backscattered signals using the PWS technique is shown
in Chapter I Section 1.1.2. In 1D weakly disorder medium, the probability density distribution of
reflectance fluctuations R, follows a log-normal distribution for all the sample length scale L,
reflected from the scattering medium. As mentioned, PWS collects the backscattered signals
propagating along the 1D trajectories since in a quasi-1D approximation the sample is virtually
divided into many parallel channels within the diffraction-limited transverse size. Then, by
applying mesoscopic light transport theory and making use of refractive index fluctuations, the
degree of disorder strength is calculated. In particular, the rms value of the reflection intensity
<R(k)>rms and the spectral auto-correlation of the reflection intensity C(Δk) for a given pixel at
position (x,y), are combined to define the degree of disorder strength as [16,17,68] discussed in
Chapter I Section 1.1.2:
31

𝐿𝑑 =

(𝛥𝑘)2
𝐵 𝑛02 ⟨𝑅⟩𝑟𝑚𝑠
|
2𝑘 2
− 𝑙𝑛(𝐶(𝛥𝑘))

𝛥𝑘→0

(2.1)

Where B is the normalization constant, n0 is the average refractive index of the weakly
disordered medium, k is the wavenumber (k = 2/), and (Δk)2/ln(C(Δk)) is obtained by
performing a linear fit of ln(C(Δk)) vs (Δk)2.
2.2.3

Tissue microarrays (TMA) samples
TMA is a rapidly growing commercially available tissue sample that consists of generally

numerous different cases of 5μm thick tissue cores in diameter 1.5mm placed on the same glass
slide for simultaneous analysis. These paraffin-embedded TMA samples allow the highthroughput analysis of tissue samples since different cases of samples have exact experimental
conditions and batches of reagents. TMAs are therefore scientific, cost-efficient, and offer an
unprecedented degree of standardization for the conduction of an experiment such as optical
imaging [69].
Here, using the PWS, we quantify the structural properties of paraffin-embedded TMAs
from US Biomax of the pancreas (T142b), breast (BR248a), colon (T054c), and prostate (T191a)
cancer samples, due to progressive carcinogenesis. Each TMA consists of different cores of
normal, stage I, stage II, and stage III cancer tissue samples. Different cores of each TMAs are
from individual patients of varying ages and sex. However, for each stage of each cancer, at least
two different cores of the same age and sex were analyzed to calculate the degree of structural
disorder.
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2.3

PWS result of structural disorder and discussions
To develop a standardized diagnostic clinical research test for early and effective

detection of cancer stages of varying types of the deadliest cancers, the structural alterations
were quantified using a finer focusing PWS technique of TMAs. Here, the degree of disorder
strength (Ld) for different stages of pancreatic, breast, colon, and prostate cancer TMAs were
computed and compared. The results show that structural alterations increase with the
progression of cancer stages in each type of progressive cancer. Since the disorder strength (Ld)
is the product of the variance and spatial correlation length of the refractive index fluctuations,
these results indicate that the progression of cancer increases more mass
rearrangement/accumulations in the tissue results in increasing the refractive index spatial
fluctuations increasing the Ld. In addition to the earlier findings, this work explores the
application of the developed, highly sensitive PWS technique to detect the nanoscale fluctuations
in paraffin-embedded TMA tissue samples of four different deadly cancers.
For each type of cancer TMAs: pancreatic, breast, colon, and prostate tissue
spectroscopic images were recorded in the visible range (450-700nm) of light from three
different cores of the same type. From each core tissue sample, at least 5 different realizations
were made for the PWS analysis. Using this powerful spectroscopic technique, the pixel-wise
refractive index fluctuations of tissue were computed and first represented in the 2D Ld
map/image, averaged over the depth of the sample. Then, the ensemble average and standard
deviation (std) of the disorder strength (Ld) were computed and presented in a bar graph for all
cancerous TMAs studied.
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2.3.1

Pancreatic cancer (PC) TMA samples
Pancreatic cancer is a lethal condition worldwide due to poor outcomes and a rising

incidence rate. It is the 3rd leading cause of cancer deaths in the US common in both men and
women and often presents at an advanced stage which contributes to a poor five-year survival
rate [70]. Because of its physical orientation and lack of early symptoms, a better understanding
of the symptoms associated with PC and its risk factor is essential to both health professionals
and individuals. Therefore, we focus our research with added finer focusing on the existing
PWS technique for the early diagnosis and to understand the structural properties of pancreatic
tissue with progressive carcinogenesis using TMA tissue samples. The results show that mass
density or refractive index fluctuations increase with the increase in the PC stage. Fig 2.2. (a)(b) and (a’)-(b’) are the representative bright-field and their corresponding Ld images of normal
and stage III PC tissue. The Ld map, which is a 2D image average along the z-axis represents the
refractive index fluctuations at that point. The Ld map shows stage III pancreatic cancer sample
has more red spots which indicate higher refractive index fluctuations in the color map. Further,
the average and std of the degree of disorder strength were calculated and represented in the bar
graph, Fig. 2.2. (c)-(d). Both the average and std of Ld value increase from normal, to stage I,
stage II, stage III with a significant difference (Students t-test p-values<0.001). This result,
therefore, suggests that the developed finer focusing PWS technique is sensitive enough to detect
nanoscale changes in refractive index fluctuation and to distinguish the different stages of cancer
in paraffin-embedded pancreatic TMA samples.
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Figure 2.2

PWS study of pancreatic cancer TMA samples.

(a) and (b) are the representative bright-field images of normal and stage III PC TMA tissue
while (a’) and (b’) are their corresponding Ld images. (c) and (d) are the bar graph representation
of the average and std of disorder strength (Ld) for normal and different stages of PC TMA. The
PWS analysis of TMA tissues shows that both the average and std of Ld value increase from the
normal to higher stages of PC. In reference to the normal, the std of Ld value of cancer stage I is
23%, stage II is 36%, stage III is 69% higher (Student’s t-test p-values < 0.001, n=15).
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2.3.2

Breast cancer (BC) TMA samples
Breast cancer is the most common cancer in women and a challenging cause of cancer

death in the world. This metastatic cancer is transferable to different organs such as the bones,
lungs, liver, and brain with almost incurability. Early diagnosis of BC is only the best method of
prevention. Although the five-year relative survival rate of an early detected BC patient is more
than 80% nowadays, oncologists and scientists are still struggling to develop a technique that can
identify early symptoms and distinguish the nanoscale structural changes in breast cancer
cells/tissue [71]. BC is the second leading cause of cancer death in women in the US. In the
existing scenario, the finer focusing PWS technique was applied to characterize the structural
properties of BC TMAs tissue at the nanoscale level due to progressive carcinogenesis. The
result shows that the structural disorder (Ld) increases from the normal to stage III significantly
as shown in Fig. 2.3. The representative Ld images Fig. 2.3. (a’)-(b’) for normal and stage III
cancer were presented which shows that the refractive index or mass density fluctuations are
higher in stage III BC. Also, the average and std of Ld value increase significantly from stage I,
stage II, to stage III about the normal with Student’s t-test p-values < 0.001 as represented in Fig.
2.3 (c)-(d). This increase in the degree of disordered strength due to progressive carcinogenesis
indicates that the refractive index fluctuations increase with the stages of cancer which was
successfully detected by finer focusing PWS using TMAs.
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Figure 2.3

PWS study of breast cancer TMA samples.

(a) and (b) are the bright-field images while (a’) and (b’) are the Ld images of the normal and
stage III BC of TMA tissue, respectively. (c) and (d) are the bar graphs of average and std of
disorder strength (Ld)for the normal and different stages of BC TMA samples. The PWS result
using TMA tissue shows that both the average and std of Ld value increases from normal to
higher stages of cancer tissue. In reference to the normal, the std of Ld value of cancer stage I is
16%, stage II is 21%, stage III is 38% higher (Student’s t-test p-values < 0.001, n=15).
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2.3.3

Colon cancer (CC) TMA samples
Colorectal cancer is predominant cancer accounting for approximately 10% of all cancer

mortality in the world. Colorectal cancer is the 3rd leading cause of cancer-related death in men
and women in the US. Population aging, improper dietary habits, smoking, low physical activity,
and obesity are the main reasons for annually increasing metastatic CC cases [72,73]. Until
modern times, laparoscopy surgery has played a vital role in controlling or treatment for primary
and metastatic colorectal cancer. Despite advances in surgical and medical therapies, the long
survival rate of colorectal patients has changed very little in recent times. This demands
standardization in screening or imaging techniques to detect the early stages of CC. Therefore, to
understand the structural changes in cells/tissue at the nanoscale level due to progressive CC we
apply the PWS technique to distinguish different stages of CC TMAs tissues. The averages and
std of the degree of disorder strength (Ld) increase from the normal to stage III with a significant
difference (Student’s t-test p-values<0.005). As cancer increases, mass density accumulation
increases which in turn increases the change in refractive index fluctuations resulting in
increased Ld value for higher cancer stages. In addition to this, the Ld images were also
constructed to visualize how the refractive index fluctuations increase with the increase in cancer
stages in colon TMAs as shown in Fig. 2.4. (a’)-(b’). The bar graphs show that the average and
std of Ld value increases in stage I, stage II, and stage III cancer tissues compared to normal, and
this result is presented in Fig. 2.4 (c)-(d).
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Figure 2.4

PWS study of colon cancer TMA samples.

(a) and (b) are the bright-field images of the normal and stage III CC TMA tissue and (a’) and
(b’) are their respective Ld Images. (c) and (d) bar graphs of the average and std of disorder
strength (Ld) for the normal and different stages of CC TMA samples. The PWS result of TMA
tissue shows that the average and std of Ld value increases from normal to higher stages of colon
cancer. In reference to the normal, the std of Ld value of cancer stage I is 23%, stage II is 32%,
stage III is 40% higher (Student’s t-test p-values < 0.001, n=15).
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2.3.4

Prostate cancer (PC) TMA samples
Prostate cancer is common cancer among men, especially elderly ones, and 1 in 9 men

will have prostate cancer during their lifespan. Ceasing to smoke, proper exercise, and weight
control are good health practices that may reduce the risk of developing PC. Although
remarkable progress has been achieved on characterizing risk factors and identifying therapeutic
options. Screening for and diagnosing the early stages of PC is still one of the most challenging
issues across the globe in medicine [74,75]. At this point, the study of structural properties of PC
tissue at the nanoscale level using a precise volume scattering technique, PWS of TMA tissue
could help to characterize the structural change in their stage. The results obtained using the
PWS technique to study the commercially available prostate TMA is presented in Fig 2.5. The
representative Ld images i.e. Fig. 2.5 (a’)-(b’) show that stage III Prostate cancer has more red
spots in the color map because it has higher mass density or refractive index fluctuations than
normal. To quantify the structural abnormalities, the average and std of the degree of disorder
strength (Ld) were computed and represented in the bar graph, as shown in Fig. 2.5 (c)-(d). As
can be seen from the figure, both the average and std of Ld value increase in stage I, stage II, and
stage III compared to normal. This increase in the Ld is due to the increase in refractive index
fluctuations with the increase in the stages of PC.
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Figure 2.5

PWS study of prostate cancer TMA samples.

(a) and (b) are the representative bright-field images of the normal and stage III PC TMA tissue
while (a’) and (b’) are their corresponding Ld images. (c) and (d) are bar graphs of the average
and std of disorder strength (Ld) for the normal and different stages of PC TMA samples. The
PWS analysis of TMA tissue show both the average and std Ld value increases from the normal
to higher stages of cancer tissue. In reference to the normal, the std Ld value of cancer stage I is
32%, stage II is 46%, and stage III is 65% higher (Student’s t-test p-values < 0.001, n=15).

41

2.4

Conclusions
In summary, as an alternative method in cancer diagnostic research of applying the

mesoscopic physics-based PWS technique using commercially available TMAs has been reported.
This technique makes the use of the recently developed finer focusing PWS technique which can
scatter precise volume to detect the nanoscale structural changes in paraffin-embedded tissue and
distinguishes the stages of four different cancer cases. To validate the purpose method, the degree
of disorder strength (Ld) of different tissue with the progression of cancer stages of different TMAs
are quantified. The PWS results obtained for some of the deadliest cancer TMAs: pancreatic,
breast, colon, and prostate show that the average and std disorder strength (Ld) increases
significantly as cancer progresses through the different stages. However, the more prominent
changes were found in the std of the degree of Ld value for all case studies. The results obtained
by the purposed method were following the earlier studies [17,59] and therefore, the Ld parameter
acts as a potential biomarker to distinguish and standardize the cancer stages which seems almost
impractical. In addition to this, the use of the PWS technique and commercially available TMAs
could provide easy and clinically accessible samples to study the drug effect in cancer treatment.
In particular, this finding invites the research communities to work with a common goal to
standardize early and accurate detection of the cancer stages of different types of deadly cancer
cases. Further validation in distinguishing the stages of cancer of TMA tissue can be performed
using other quantitative approaches such as fractal, IPR, etc. [62,76,77]. Lastly, the flexibility
provided using the spectroscopic technique such as PWS in commercially available TMA samples
to distinguish the early to late stages of cancer cases opens a broad way to explore and generalize
the structural changes in progressive cancer for effective diagnosis and drug treatment in the future.
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CHAPTER III
OPTICAL QUANTIFICATION OF STRUCTURAL PROPERTIES OF TUMOR TISSUES
GENERATED BY XENOGRAFTING OF CANCER CELLS USING PWS
This chapter is adapted from the author’s published article with copyright permission
from the publisher. Ref. [53] P. Adhikari et. al., “Optical detection of the structural properties of
tumor tissue generated by xenografting of drug-sensitive and drug-resistant cancer cells using
partial wave spectroscopy (PWS)”. Biomedical Optics Express, BOE. 2019 Dec 1;10(12):6422–
31. The PWS technique has been successfully used for the detection of cancer stages by probing
nanoscale structural alterations in cells/tissues as discussed in Chapter II. However, the
development of drug-resistant cancer cells/tissues during chemotherapy is a major challenge in
cancer treatment, especially to know the drug is working or not. In this chapter, using a mouse
model and developed PWS technique, the structural properties of tumor tissues grown in 3D
structures by xenografting drug-resistant and drug-sensitive human prostate cancer cells having
2D structures are studied. In particular, we probe the difference in the structural disorder of cells
grows on 2D slides or cells grown in a 3D environment inside the body. This may provide us an
indirect way to study the effects of drugs on the cancer cells/tissues. The promising aspect of the
proposed study to establish insight into advancing the understanding of the physical state and
drug effectiveness on cancerous cells/tissues at the nanoscale level is explored.
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3.1

Introduction
Elastic light scattering, especially in the visible range of light, is an important method for

probing structural morphologies of the biological cells/tissues. It is now shown that probing the
structural alteration at the nano to submicron scales enables the prediction of several properties
of the physical conditions of cells/tissues in normal and disease/abnormal states. Recent studies
have shown that the progression of carcinogenesis results in nanoscale structural alterations due
to the rearrangement of the basic building blocks, in particular, macromolecular components
inside the cells. These nanoscale structural alterations, in terms of the degree of disorder
strength, have been shown as an important biomarker in the determination of cancer
stages [22,23]. However, the histopathological examinations of cells/tissues, conventionally, are
based on a large degree of changes in the cellular architecture, mainly nuclear size, during the
disease process [78–81]. Also, the sensitivity of the existing pathological optical microscopic
techniques used to detect such nanoscale alterations is restricted by the diffraction-limited
resolution (>~200nm).
A recently introduced spectroscopic microscopy technique, partial wave spectroscopy
(PWS), combines the interdisciplinary approaches of mesoscopic condensed matter physics and
microscopic imaging, to quantify the degree of change of the nanoscale structural disorder of
weakly disorder medium like biological cells/tissues [15–17,59,60,67]. The statistical
quantifications of the reflected intensities due to the nanoscale refractive index fluctuations of
the biological cells/tissues are carried out using the PWS analysis. In the PWS technique, the
backscattering signals from thin weakly disordered cell/tissue samples are divided into many
parallel scattering quasi-one-dimensional reflections to calculate the structural disorder strength
of the samples. Further, the spatial variation of the intracellular components such as DNA, RNA,
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lipids, and extracellular matrices (ECM) gives rise to spatial mass density fluctuations in terms
of the refractive index fluctuations of the cells/tissues. This spatial refractive index fluctuations
can be quantified in terms of the degree of structural disorder. The degree of structural disorder
parameter Ld, called the disorder strength, can quantify nanoscale alterations and distinguish
different cancer stages with higher accuracy. For a quasi-1D approximation, the disorder strength
can be expressed as Ld =dn2×lc, where dn is the standard deviation (std) of the onsite refractive
index fluctuations dn(r) and lc is its spatial correlation length. The efficiency and application of
the PWS technique in measuring nanoscale alterations, i.e. the Ld parameter, to diagnose
diseases like cancer has been developed and explored [15,17,59,60,67,82]. The detection of
molecular-specific structural disorder in submicron scales of control and cancer/abnormal cell
nuclei are also studied by the light localization technique using confocal microscopy, which
supports the increase in the molecular-specific structural disorder in progressive cancer [38,83–
85].
After the diagnosis of cancer, the cancer patient generally goes through chemotherapy
drug treatment. Resistance to cancer cells/tissues to chemotherapy drugs is one of the obstacles
in cancer treatment. Recently, the PWS technique was successfully used to study the effect of
chemotherapy drugs on prostate cancer cell lines and to quantitatively measure the structural
disorder strength of drug-sensitive and drug-resistant prostate cancerous cells [59]. The results
show that the chemo-resistant cells have a higher degree of structural disorder than that of the
chemo-sensitive cells. Drug-resistant cancerous cells are able to survive chemotherapy drug
treatment, as the different mechanisms responsible for drug resistance and the development of
different morphological structures. These different morphological structures in drug-resistant
cancer cells may be due to the rearrangements of macromolecules, increase in the sizes of
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membrane pores, architectural differences of the cytoskeletal network, etc., which result in
increasing aggressiveness and the disorder strength.
Prostate cancer is one of the most prevalent types of cancer with one of the highest male
mortality rates in the USA. The American Cancer Society (ACS) estimates about 174,650 new
cases of prostate cancer will appear and account for a total of 31,620 deaths for 2019. Across the
globe, the statistical data on prostate cancer suggests that among every 9 men, one individual
will develop this cancer during his lifespan. Therefore, it is necessary to explore early and
effective diagnosis and treatment methods for prostate cancer. At present, chemotherapy is the
only way to treat metastasized prostate cancer, however, it is often found ineffective due to an
individual patient’s chemo-resistance that leads to tumor progression [59,86–90]. The PWS
studies of cancer cell lines have shown some promising success in distinguishing the hierarchy
and drug effectiveness based on the measurement of the biomarker, the structural disorder
strength Ld [59].
These PWS studies of drug resistance cells for different cell lines were mainly focused on
cancer cells that were grown in 2D on glass slides. However, in reality, a metastasizing cancer
cell grows into a tumor with a 3D structure when grown within the body, and these tumor cells
may have different structural properties due to their grown 3D tissue structures. This leads to a
demand for the development and quantitative characterization of 3D tumor tissues that are grown
from drug-sensitive and drug-resistant cancer cells. This could establish a correlation between
isolated cells of 2D structure which is grown into tissue in 3D structure, based on the structural
disorder. In particular, we want to verify the structural properties of 3D tissues generated by
xenografting of cancer cells, and to understand any relationship between the 3D tissue structures
with their original 2D cell structures, using the Ld parameter. Human cancer cases have been
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studied by innumerable murine methods and the determinants responsible for malignant
transformation, invasion, and metastasis, as well as the examination of the response to therapy, is
investigated with the aid of these murine models. Xenografting of human cancer cells in a mouse
model is one of the most extensively used models to study the development of tumors from
cells [91,92]. Cancerous human cells were subcutaneously injected in immunocompromised
mice. Based on the number of cells injected, the tumors will develop over 1-8 weeks and reaction
to the proper therapeutic regimes can be studied in vivo [91,93] or ex vivo. At the same time, the
structural properties of growing xenografted cancer cells are not well studied.
In this work, using a further engineered PWS technique, we explore the structural
properties of the 3D tumor tissues obtained by xenografting drug-sensitive and drug-resistant
human prostate cancer cells’ 2D structure using a mouse model. We study structural properties
of tissues obtained by xenografting two types of human prostate cancer (PC) cell lines, namely
DU145 and PC3, whose drug-resistant and drug-sensitive structural properties were studied
earlier by the PWS technique [59]. From the results, a correlation between the 3D structural
disorder of tissues originally grown from chemotherapy drug-sensitive and drug-resistance cells
and the original cells will be performed. Finally, we will also discuss the potential applications of
the technique in cancer diagnostics.
3.2
3.2.1

Method
PWS experimental setup
We perform the structural disorder measurement using a recently developed partial wave

spectroscopy (PWS) experimental technique, with added engineering of finer focusing as
mentioned in Chapter I Section 2.1.1 [59,60,67]. The actual experimental PWS setup developed
in the Bionophotonics laboratory is as shown in Fig.3.1. It consists of a Xenon Lamp, a source
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of stable broadband white light to illuminate tissue samples of micron thickness using Kohler
Illumination. This collimated light from the 4f combination is focused on the sample through the
objective. The use of a highly sensitive 3D electronic motorized stage (100nm on Z-axis and
40nm on the X-Y axis) provides the finer focusing of the sample within the working distance of
the objective. Then the backscattered signal gets reflected by a dichroic mirror towards the
detector through a liquid crystal tunable filter (LCTF) coupled with CCD.

Figure 3.1

Actual PWS experimental setup developed in Bionanophotonics laboratory, MSU.

The table-top optical instrumentation of PWS setup. It consists of a board band white light
source collimated through the 4f combination of the lenses. The nanoscale sensitive 3D
motorized scanning stage is used for the precise focusing of the sample to capture the
spectroscopic image using CCD.
3.2.2

Calculation of the structural disorder or disorder strength (Ld)
The backscattered images are recorded in the CCD camera at every wavelength () at the

spatial pixel position (x,y) in the wavelength range 450-700nm, and the reflected data cube, R(x,
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y; ), is acquired by the PWS system. In a quasi-1D approximation, the collected backscattered
data at each (x,y) from R(x,y;) is fitted with a polynomial of the 5th order. The fitted polynomial
is then extracted from the signal to remove the systematic errors. In the next step, the R(k) signal
for each pixel position (x,y) is obtained after applying a 5th order low-pass Butterworth filter with
a suitable normalized cutoff frequency to remove the high-frequency noise components from the
reflected signals of micron size samples. Here, calibration of the system is done by matching the
reflected intensity pattern using a non-disordered system, NIST-traceable microspheres with the
reflected signal from a thin film slab model.
The fluctuating part of reflection signals R(x,y;) arises due to the multiple interferences
of the photons reflected from the disordered medium. Since in a quasi-1D approximation, the
sample is virtually divided into many parallel channels within the diffraction-limited transverse
size, and the backscattered signals propagating along the 1D trajectories are collected. The
statistical properties of nanoarchitecture are quantified at the nanoscale level by analyzing the
fluctuating part of the reflected intensities. The refractive index fluctuation information is
collected from these spectral fluctuations originated from the multiple scattering of the sample at
any length scale below the diffraction limit. The degree of structural disorder Ld can be derived
from the rms value of the reflection intensity <R(k)>rms and the spectral auto-correlation decay of
the reflection intensity C(k) ratio. That means, for a given pixel at position (x,y), the degree of
structural disorder is expressed as shown in Chapter I Section 1.1.2 [16,17,59,60,67]:
(𝛥𝑘)2
𝐵𝑛02 ⟨𝑅⟩𝑟𝑚𝑠
𝐿𝑑 =
|𝛥𝑘→0
(3.1)
2𝑘 2
− 𝑙𝑛(𝐶(𝛥𝑘))
where B is the normalization constant, n0 average refractive index of the biological cells, and k is
the wavenumber (𝑘 = 2𝜋/𝜆).
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Therefore, the disorder strength quantifies the variability of the local density of
intracellular material within the samples, and hence the average and standard deviation of the Ld
values are calculated to characterize the structure of the system.
3.2.3

Sample preparation
Freshly collected prostate cancer (PC) cells from two different cell lines were used to

develop a prostate xenograft, mouse model. For the generation of tumor xenograft mouse
models, 6–8 weeks old male nude mice were implanted with PC3 (docetaxel-sensitive and
docetaxel-resistant) and DU145 (docetaxel-sensitive and docetaxel-resistant) human PC cell
samples (2 × 106 cells per mice), by subcutaneously injections. After tumors reached beyond the
critical size of 1000 mm3, they were excised from euthanized mice. The excised tumors were
further paraffin-embedded and sectioned using microtome in 4μm thickness and placed on glass
slides. Further, these slides were processed for the antigen retrieval process as described
previously [94]. The resultant tumor sections were subject to imaging studies.
3.3

Results
PWS detects the nanoscale structural alterations in the cells/tissues and can distinguish

the different levels and effects of the drug in the tumorous cells/tissues [16]. Among the
different types of cancer, prostate cancer is a major concern of public health at present because
of its low survival rate. Further, drug-resistant cancer cells are a prominent problem currently in
cancer treatment. Therefore, we focus our research to characterize the structure of tumor tissues
generated by the xenografting of chemotherapy drug-sensitive and drug-resistant prostate cell
lines, DU145, and PC3. For this, human drug-sensitive and drug-resistant prostate cancer cells
were subcutaneously injected into mice and allowed to grow and achieve a tumor size of
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~1000mm3. After that, mice were euthanized, and tumors were excised then subsequently
processed to 4 µm thick tumor sections on slides for PWS imaging analyses.
PWS experiments, as described earlier, were performed on xenografted prostate tumor
tissues for each category on at least 3 different mice. All tumor tissue was obtained from
different prostate cancer cell lines xenografted into mouse models. For each tissue sample, PWS
experiments were performed on 7 different spots. In particular, for each category of a tumor, ~60
different spots are experimented with PWS and analyzed. The spectroscopic PWS experiments
are performed in the wavelength range 450-700nm. The backscattered data matrix R(x, y; ) are
imported and the disorder strength for each tissue is calculated using the PWS technique as
described in section 3.2. The disorder strength is calculated as the product of the variance and the
spatial correlation length of the refractive index fluctuations. The average and standard deviation
of the disorder strength for each category are calculated in order to understand the physical
properties of a tumor developed as a 3D structure from a cell. The detailed PWS analysis of a
tumor obtained from a xenografted model of drug-sensitive and drug-resistant cell lines DU145
and PC3 are explained below:
3.3.1

Structural disorder in the xenografted DU145 tumor tissue type
In Fig. 3.2, the PWS analysis of tumor tissues obtained from xenografting drug-sensitive

and drug-resistant prostate human cancer cell lines of DU145 type are shown. From the PWS
experiment R(x,y,) data matrixes were obtained. At every pixel point (x,y), R(k)rms value and
corresponding C(k) were obtained, and from these two values, and the Ld value was calculated
using Eq.(2.1). The bright-field images, as shown in Fig. 3.2(a)-(b), the thin tissue samples
developed from drug-sensitive and drug-resistant cancer cell lines appear indistinguishable,
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whereas the Ld images are noticeably distinguishable. The red spots in the Ld image represent a
higher disorder strength, i.e. the Ld value of that pixel. It can be seen in the bar graphs that there
is an increase in the degree of structural disorder of tumor tissue generated from xenografting
drug-resistant cancer cells, compared to the tissues obtained from xenografting drug-sensitive
cancer cells. The average Ld value of a tumor obtained from a drug-resistant cancer cell line is
9% higher than the tumor obtained from a drug-sensitive cancer cell line and the standard
deviation std(Ld) is 8% higher. This result is in strong agreement with the disorder strength
calculated for drug-resistant and drug-sensitive cell lines earlier [59]. The disorder strength of
the prostate cancer cell line calculated using PWS has shown that the average and standard
deviation of Ld value is higher in drug-resistant cells compared to the drug-sensitive for DU145
type cells. The results confirm that the xenografted tissue structures also have similar trends to
original cell structures.
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Figure 3.2

The structural abnormalities in tumor xenografted from DU145 cells lines.

(a) and (b) are the bright-field images while (a’) and (b’) are the disorder strength or Ld
images of tissue obtained by xenografting drug-sensitive and drug-resistant PC cells line of
DU145 type respectively. (c) and (d) are the graphical representation of the mean and standard
deviation of Ld of the xenografted tumor, respectively. Result shows a 9% higher mean Ld and
8% increase in the std Ld in a tumor developed from drug-resistant PC DU145 type cells line
than the drug-sensitive cells. P-values < 0.05.
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3.3.2

Structural disorder in the xenografted PC3 tumor tissue type
Fig 3.3 (a)-(b) shows the bright field and Ld images of tumor tissues originated from

drug-sensitive and drug-resistant PC PC3 type cells. Based on the intrinsic properties of the
tissue, the disorder strength Ld at each pixel of the individual tissue image is calculated and
represented by 2D color maps. In the color map, red spots correspond to the higher structural
disorder strength present in the thin tissue structure (averaged along the z-direction of the
sample). The bar graphs, 3.3(c) and (d) are the representation of the average and standard
deviation of Ld values with the standard error bars. The result shows a 12% difference in the
average local disorder strength Ld and a 15% difference in the std (Ld), between tumors obtained
from drug-sensitive and drug-resistant cell lines. The increment in the mean and standard
deviation of Ld for tissues collected by the xenografting of drug-resistant PC PC3 cells compared
to the drug-sensitive PC PC3 cells are consistent with the original cell structures. It is clear from
the plots that the disorder strength increases from drug-sensitive to drug-resistant xenografted
tumor tissues. Earlier results using PWS analysis show that PC PC3 cells are more aggressive
than other cell lines and in the same way drug-resistant PC cell lines have higher disorder
strength than drug-sensitive cells. Figs. 3.2 and 3.3 show the results obtained using xenografted
tissue samples also have the same kind of disorder strength hierarchy as that of the original PC
cells. In particular, a comparatively higher structural disorder strength Ld for tumors obtained
from drug-resistant PC PC3 cell lines than PC DU145 cell lines are in strong agreement with
their original PC cell line disorder strength. This confirms that the degree of disorder strength Ld
can be used as a marker to detect the cancer stages or drug effects using 3D cancer tissue
structure, similar to that of a cell line that is easy to study.
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Figure 3.3

Structural abnormalities in tumor xenografted from PC3 cells lines.

(a) and (b) are the bright-field images and (a’) and (b’) are the disorder strength or Ld images of
tissues obtained by xenografting of drug-sensitive and drug-resistant PC cells line of PC3 type
respectively. (c) and (d) are the bar graph representation of the mean and standard deviation of Ld
of a tumor, respectively. Result shows a 12% higher mean Ld and 15% increase in the std Ld in
tumors developed from drug-resistant PC PC3 type cells line than the drug-sensitive cells. Pvalues < 0.05.
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3.4

Conclusions
The results indicate that tumor tissues grown by xenografting of PC cells resistant to

docetaxel have a higher disorder strength Ld than the same tissues from drug-sensitive PC cells.
Since the disorder strength increases with the increase in the level of tumorigenicity, which
implies chemotherapy-resistant cells are more aggressive than drug-sensitive cancerous cells.
Cells from the prostate or any other cancerous region that survived through drug exposure are
more aggressive and develop with the cell line’s hierarchy as PC3 > DU145 [59]. As an
application of the developed finer focusing PWS technique, we have studied the structural
alteration in the xenografted tissue morphology that is grown in a 3D environment from single
cells that mainly have 2D structures. The results show metastasize isolated 2D cancer cells
grown to 3D tumors in the body have similar structures and characteristics. The PWS analysis of
3D tissue slices confirm xenografted tissues from drug-resistant tumors have a higher average
and standard deviation of disorder strength (Ld) than the drug-sensitive counterparts. Also, the
obtained results follow a similar hierarchy of the cell lines that are studied earlier, reported in
ref [59].
Probable cause of structural properties of drug resistance cells/tissues and higher
structural disorder (Ld): Studies have shown that the progress of cancer disturbs the regular
growth as well as the structure of cells/tissues. Further, cells/tissues that survive through the
chemotherapy adapt themselves to the situation and develop different morphological structures
resulting in higher mass density fluctuation due to the rearrangement of macromolecules, larger
pore sizes, changes in cytoskeleton nanoarchitecture, etc. This results in a higher structural
alteration in drug-resistant PC cells than drug-sensitive ones. The different mechanisms such as
tumor-derived exosomes biogenesis and composition, DNA and histone damage/repair, anti56

cancerous multidrug inactivation, alteration in drug targets treatment, heterogeneity in cancerous
cells/tissues, death inhibition of cells/tissue, epithelial-mesenchymal transition, and metastasis,
etc. [95–99] are making the cancerous cells/tissues drug-resistant [59]. Xenografted tumor
tissues that are obtained using cells from drug-resistant and drug-sensitive PC cell lines, main the
same types of structural hierarchy properties when they are grown into 3D structures. This
supports a strong correlation in structural properties in 2D and 3D structures.
Applications of the developed technique for cancer treatment: The PWS study of
xenografted tissues obtained from drug-sensitive and drug-resistant PC cells line could establish
a new insight into advancing the understanding of the physical state and drug effectiveness on
cancerous cells/tissues at the nanoscale level, by knowing their structural properties. The
xenografted tissue structure replicating the structural properties of cancer cells explained
statistically in terms of the disorder strength Ld parameter could be a reliable, easy, and
quantitative approach to diagnose chemoresistance. This result seeks the potential application to
monitor the effect of chemotherapy drugs on cancerous tissues and to study the different levels
of tumorigenicity which can be obtained both, in-vitro and in-vivo methods. In summary, this
method will help in understanding the drug-resistant and drug-sensitive cells/tissues and their
different stages in the body, by examining their structural disorder properties.
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CHAPTER IV
PHOTONICS TECHNIQUE TO QUANTIFY PROBIOTICS EFFECT ON CHRONIC
ALCOHOLIC BRAIN CELLS VIA MOLECULAR-SPECIFIC CONFOCAL-IPR
This chapter is adapted from the author’s published article with copyright permission
from the publisher. Ref [58] P. Adhikari et al., “Photonics study of probiotics treatment on brain
cells exposed to chronic alcoholism using molecular specific light localization properties via
confocal imaging”. arXive. 1912.11777, 2019. And Ref [59] P. Adhikari, et al., "Quantification
of light localization properties to study the effect of probiotic on chronic alcoholic brain cells via
confocal imaging," in Imaging, Manipulation, and Analysis of Biomolecules, Cells, and
Tissues XIX (SPIE), 2021, Vol. 11647, p. 1164716.
Recently IPR technique using confocal images has shown success in distinguishing molecularspecific structural alterations targeting DNA to quantify cancer, radiation effect, or any other
abnormalities in cells/tissues [38,100]. The advantage of the IPR technique relative to the PWS
technique is that we can probe structures of an isolated cell within the tissue without disturbing
them by confocal imaging, which is not possible using the PWS technique. PWS technique
provides statistical properties of the region averaged over light propagation direction and it
cannot probe separately a cell that is situated inside the tissue. It was found that chronic
alcoholism introduces abnormalities in brain cells/tissue that result in behavioral and
psychological disorders. On the other hand, probiotics such as Lactobacillus Plantarum enhances
brain functions in chronic alcoholism. Therefore, in this chapter, using the close scattering based
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on light localization technique, IPR combined with confocal imaging we probe the molecular
specific structural alterations present in chronic alcoholic brain cells with or without probiotic
treatments in a mouse model. The potential application of this novel approach to diagnose the
alcohol effect and probiotic treatment in the alcoholic brain is explored.
4.1

Introduction
Photons/light are an important probe for the characterization of the structural properties

of biological cells. It is known that the structural properties of cells and tissues change with the
progress of disease or abnormalities such as cancer, stress, drugs, etc. Cells and tissue are weakly
disordered dielectric media; therefore, their structure and any change in the structural properties
can be characterized using light, which happens at the length scale of micron size. The light
probing is generally done by measuring the scattering signals and quantifying the optical
parameters of the samples. Different types of structural changes can happen in a cell with the
progression of diseases such as carcinogenesis or due to the effect of drugs [23,22,58]. These
changes in a cell may range from bulk structural change to nanoscale molecular-specific
structural alterations. The nanoscale structural changes in cells and tissues due to diseases or
abnormalities are associated with the molecular-specific structural alteration and, in turn, its
mass density fluctuations. Recently, the refractive index fluctuations are experimentally
measured to quantify the structural abnormalities in cells and tissues using the recently
introduced mesoscopic physics-based sensitive imaging technique called, the
PWS [16,17,58,60,67,68,101]. Although the microscopic changes in a cell/nucleus have been
studied for a long time by probing structural properties, however, these changes appear almost at
the advanced stages of diseases or abnormalities, which would be too late for treatment. At the
same point, the PWS technique can probe full structural changes of a cell or tissue, and it was
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recognized that minuscule changes occur at the early stages of the diseases or abnormalities
where the molecular specific nanoscale structural changes occur due to the rearrangements of the
macromolecules present in a cell. Therefore, probing molecular-specific structural changes will
be more efficient and important for the detection of abnormalities or disease progression in a
cell. This is the primary interest of the present study. Therefore, we hypothesize that probing the
molecular-specific structural changes can measure the physical state of cells/tissues and the
organs. The concept of characterizing the molecular-specific structural alterations was
introduced recently to quantify the nano to microscale changes in cells in abnormalities and has
shown success in several studies [22,23,61,83]. The initial case studies ranging from cancer to
abnormalities in brain cells due to chronic alcoholism have shown promising results in the
characterization of the physical state of the cell [38,61,83,102].
Alcohol-related disorders and organ-specific damage are significant global concerns.
Alcohol and its metabolites play a significant role in neuroinflammation, however, the existing
evidence indicates that interactions at the Gut-Microbiome-Brain axis are a crucial part of the
alcohol-related behavioral disorder [103,104]. Among the multidirectional alcohol interactions
with the human body, initially, chronic alcoholism affects the brain from the cellular to the
molecular level. It has been shown by TEM imaging that structural properties of the cells change
in chronic alcoholism at the nanoscale level, and alterations are prominent at the length scales of
~100nm, which is around the length scales of the building blocks of cells [18]. Glial cells such
as astrocytes and microglia, as well as the chromatin of the cell nuclei present in the cerebral
cortex of the brain, which totals the vital portion of the central nervous system (CNS), are
profoundly affected by chronic alcoholism. Chronic alcoholism can produce sustainable damage
in the brain on different length scales. This structural damage can bring neuropathological
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disorders such as memory loss and dysfunction of the brain resulting in cognitive and behavioral
deficits [105–107].
In the brain cells, the star-shaped astrocytes and microglia are the most abundant glial
cells present in the CNS and mostly serve as a regulator of the CNS’s immunity and tissue
transplantation. In the same way, chromatin in all brain cells plays an important role in genetic
inheritance. In humans, it is reported that a single astrocyte interacts with two million neurons at
a time [108]. These astrocytes perform various tasks such as axon guidance, synoptic support,
controlling blood flow, and blood-brain-barrier function. Along with regulating behavior, they
play a vital role in neuroinflammation in both beneficial and detrimental ways depending on the
stimuli they receive from their inflamed environment. Similarly, microglia act as the role of
tissue macrophages which are involved in immune response, removing damaged neurons, tissue
transplant, and other neurological mechanisms and diseases. However, alcohol is one of the most
well-known adverse incentives for neuroinflammation. Pathogenesis of many CNS disorders and
several neurodegenerative diseases are crucially caused by brain inflammation [109]. This
inflammation activates the glial cells, specifically the microglia and astrocyte, and liberates the
free radicals, cytokines, and inflammatory mediators that can damage normal brain
function [110]. A recent study showed that alcohol treatment in the microglial cells and
chromatin altered their morphology [111].
In some cases, these structural alterations may be reversible to a good degree through
different types of treatments. It was reported that probiotic treatment has a good effect on brain
health. In particular, it can soothe human brains and reduce structural abnormalities in brain
cells/tissue to a certain extent [112,113]. Immunofluorescence results also show that probiotic
treatment such as Lactobacillus Plantarum, when administered after a chronic alcohol-induced
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injury can rescue the alcohol-induced systemic inflammation and neuroinflammation resulting in
improving the physical state of human brains [114]. L. Plantarum is a Gram-positive lactic acid
bacterium present in fermented food and anaerobic plant matter which has ample applications in
the medical and biomedical fields. In particular, L. Plantarum blocked alcohol-induced gut
barrier dysfunction, endotoxemia, and liver damage which are directly associated with the wellfunctioning of the brain [115]. Therefore, we are using the recently developed mesoscopic
physics-based light localization technique, IPR, which can quantify the molecular specific mass
density fluctuations in cells/tissue as the degree of structural disorder due to diseases or any other
abnormalities [22,23,38,102]. In the IPR technique, an optical disordered refractive index matrix
is constructed based on the pixel intensities via confocal imaging and solved for optical
eigenvalues and the eigenfunctions using the closed boundary conditions. Based on the
mesoscopic theory, these eigenfunctions are used to quantify the molecular specific light
localization properties of samples, that can be represented by the average of IPR, <<IPR>>, and
the standard deviation (std) of IPR, (<IPR>), of these eigenfunctions. The earlier IPR study
results show that the degree of disorder strength i.e., Ld = <dn>×lc is proportional to <<IPR>>
or (<IPR>) [38,83]. This technique has been used to quantify the extent of aggressive cancer
in biological cells, especially to detect the progress of carcinogenesis in drug
treatment [38,62,83]. Here, we want to extend this method to probe the molecular-specific
spatial structural changes in brain cells and organelles to study the effect of probiotics in chronic
alcoholism.
In this work, using the IPR technique via confocal imaging, we report the effects of
alcohol in glial cells, and molecular DNA/chromatin structure in nuclei of mice brain cells in the
cortex region by probing molecular specific structural changes. Then, the effect of probiotic
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treatment in the glial cells and nuclei of the brain cells for the following cases: control, only
alcohol fed, only probiotic fed, and simultaneously alcohol and probiotic fed were studied to see
the effect of probiotics on the chronic alcoholic brain, using a mouse model.
4.2
4.2.1

Methods
Molecular specific structural disorder via confocal imaging and IPR technique
Confocal imaging is a technique that captures images with high optical contrast and

resolution ranging in the submicron length scales. The confocal microscopy and its schematic are
briefly explained in Chapter I Section 1.2.2. In confocal microscopy imaging, a spatial pinhole is
used which blocks out-of-focus light to acquire a controlled depth of field and reduce
background lights in images. For a confocal image, the amount of fluorophore dye that binds a
molecular mass is proportional to the molecular mass density at any point or a small voxel. In
general, dyes are independent of each other, and treating a cell with different molecular binding
dyes at the same time and probing them with appropriate wavelengths can provide us the various
molecular specific spatial structural mass density fluctuations in a cell using the IPR technique.
The submicron scale mass density fluctuations are quantified by calculating the degree of
structural disorders in confocal images using the IPR technique. In the IPR technique, an optical
lattice is formed using the pixel intensities of the confocal images which represent the ‘mass
density fluctuations’ that were scanned voxel-wise. Based on the light localization strength, the
average IPR or the disorder strength is computed. A higher value of the <IPR> represents an
increase in the mass density fluctuation in the cell or molecule. Henceforth, the average of
<<IPR>> or (<IPR>) ultimately quantifies the degree of structural disorder in the medium.
The theoretical model of the IPR technique has been reported earlier in Chapter I Section
1.2.3 [22,23,38,62,83] in detail; however, in this chapter, we will describe the technique in short.
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As mentioned in [38,83], let us consider a pixel intensity I(x,y) of the confocal image at
position r=(x,y) and ρ is the density of the molecule at voxel dV of the image is I(r)=dV().
It was shown in [38,116] that the local refractive index of the cell slice is directly proportional to
the local mass density of the cell at that point (x,y) which is directly proportional to the confocal
image intensity at any voxel that point.
The refractive index n(x,y) of thin scattering substances such as biological cells has a
linear relation to the mass density [116,117], and are correlated with the confocal image’s
intensity, I(x,y), which is linearly proportional to the mass density, M(x,y), and refractive index,
n(x,y), at the voxel as obtained in Section 1.2.3 equations (1.10, 1.11).
From this, we obtain the optical potential as i(x,y) and construct a representative
refractive index matrix using the pixel intensity value [30] given as Section 1.2.3 equation (1.12).
The optical potential, 𝜀𝑖 (𝑥, 𝑦) which is a representation of the spatial refractive index fluctuation
relative to the average of the fluorescent molecules inside the sample [33,116].
Then the Hamiltonian of Anderson's Tight Binding model [28,30,118] is obtained as
explained in Section 1.2.3 equation (1.13) of the closed system. We can generate the
eigenfunctions (Ei’s) from the Hamiltonian (H) of the system by diagonalization. Using these
eigenfunctions (Ei’s) we calculate the average IPR value, <IPR>, of the entire sample images as
defined in [22,23,32,46,47]:
𝑁

𝐿 𝐿
1
< 𝐼𝑃𝑅(𝐿) >𝐿×𝐿 = ∑ ∫ ∫ 𝐸𝑖4 (𝑥, 𝑦)𝑑𝑥𝑑𝑦,
𝑁
0 0
𝑖=1

(4.1)

Where Ei is the ith eigenfunction of the Hamiltonian H of the optical lattice size L×L, and N is the
total number of lattice points on the refractive index matrix.
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It can be shown [38,83] that the average IPR value <IPR>=<IPR(L)> is directly
proportional to the structural disorder strength, and can be expressed as:
⟨⟨𝐼𝑃𝑅(𝐿)⟩⟩ = ⟨⟨𝐼𝑃𝑅(𝐿)⟩𝐿×𝐿 ⟩𝑒𝑛𝑠𝑒𝑚𝑏𝑙𝑒 ∼ 𝐿𝑑 = 𝑑𝑛 × 𝑙𝑐 ,

(4.2)

𝜎(⟨𝐼𝑃𝑅(𝐿)⟩) = 𝜎(⟨𝐼𝑃𝑅(𝐿)⟩𝐿×𝐿 )𝑒𝑛𝑠𝑒𝑚𝑏𝑙𝑒 ∼ 𝐿𝑑 = 𝑑𝑛 × 𝑙𝑐.

(4.3)

Lastly, the <<IPR(L)>LL>ensemble =<<IPR>> and (<IPR(L)>LL)ensemble =(<IPR>)
which is directly proportional to the disorder strength (Ld) of the sample and acts as potential
biomarkers of the of biological cells to quantify any types of abnormalities in glial cells and
chromatin of the brain cells.
4.2.2

Brain tissue sample preparation using an alcoholic mouse model
We study the effects of probiotics on chronic alcoholic brain cortical cells and nuclei

using a mouse model. In particular, we will study the glial cells: astrocytes and microglia, and
the DNA/chromatin of the nuclei from cells of the cerebral cortex region of the brain which
includes the major portion of the CNS. The brain sections were incubated with glial fibrillary
acidic protein (GFAP) antibody, the microglia cells with anti-TMEM119 transmembrane protein
antibody, and the chromatin in the nuclei of brain cells with DAPI for confocal imaging [114].
The effects of alcohol and probiotics in the brain cells were studied using 8-10 weeks old
mice (C57BL/6, Harlan, Houston, TX) divided into 4 different groups of 6 mice per group. All
mice were housed in an institutional animal care facility with 12/12 of the light-dark cycle which
have easy access to regular laboratory chow and water until the start of the experiment. To be
more specific, for (1) Control (PF), (2) Ethanol Fed (EF), (3) Probiotic Fed (PF+LP), (4)
Probiotic and Ethanol Fed (EF+LP), we observed glial cells and nuclei of the brain cells, namely:
(I) Astrocytes, (II) Microglia, (III) Chromatin.
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A recent study based on immunofluorescence confocal microscopy showed that alcohol
elevates the expression of different proteins or dyes as an activation marker in different brain
cells and components to explain the alcohol effect [114]. The rationale for choosing the glial
cells and chromatin to probe the abnormalities in alcohol and probiotic treatment are: (I)
Astrocytes and anti-GFAP antibody staining: These cells represent a significant portion of the
CNS and can interact with millions of neurons at a time. They get exposed to external simulators
such as alcohol and probiotics. For confocal imaging, these cells can be easily tagged by the glial
fibrillary acidic protein (GFAP) antibody marker. GFAP protein is encoded by the GFAP gene in
humans. GFAP antibody targets type-III intermediate filaments. Intermediate filaments are
overactive/expressed in astrocytes in the CNS when the brain is exposed to a chemical such as
alcohol. Therefore, the molecular-specific type-III intermediate filament can be probed by GFAP
for confocal imaging to probe the activeness of astrocytes. (II) Microglia and anti-TMEM119
transmembrane protein antibody staining: Microglia cells are also considered as the
macrophages of the CNS and include a major portion of the CNS system, which clean up the
cellular debris and participate in neuroinflammation. These glial also easily get exposed to
alcohol or drug treatment similar to astrocytes. It is now known that overexpression or
upregulation of transmembrane protein TMEM119 in microglia due to the presence of
stimulators like alcohol/probiotic can be tagged by anti-TMEM119 transmembrane protein
antibody for the molecular specific confocal imaging. (III) Chromatin and DAPI staining: In
all brain cell nuclei, chromatin is highly abundant. Chromatin is the primary DNA molecular
component of the cell nucleus. It has been shown that chromatin spatial structures altered with
the progress of diseases and abnormalities. The chromatin can be easily stained by the standard
DAPI dye. The nanoscale changes in these types of cells are shown well for the detection of
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cancer stages. We want to probe the molecular-specific structural alteration of DNA mass
density in chromatin in nuclei by DAPI staining and confocal imaging tissue sections of the
cortex region.
Bio-Marker: The primary marker is to probe the confocal images using the IPR
technique and to quantify the molecular-specific nanoscale spatial mass density fluctuations as
the degree of structural disorder, mentioned in Section 4.2.1.
As described above, mice were randomly divided into 4 categories with 6 mice per group
and fed with ethanol following a standard protocol in Leiber DiCarli liquid diet (ethanol: 0% for
2 days, 1% for 2 days, 2% for 3 days, 4% for 1 week, 5% for 1 week, and followed by 6% for 1
week) with or without L. Plantarum (strain 256, 106 cfu/ml) or isocaloric maltodextrin for 4
weeks. Control and only probiotic fed animals were pair-fed with isocaloric substitution of
ethanol with maltodextrin. Animals were pair-fed to maintain a similar diet intake in all groups.
In the last week of experiments, the average diet intake per mouse per day was 0.7 ml which
means the L. Plantarum intake by a mouse was about 0.7 ×106 cfu/day and grouped as (1) The
first group was pair-fed with maltose dextrin in a liquid diet, (2) the second group was fed with
ethanol liquid diet, (3) the third group was fed with the probiotic in a liquid diet, and (4) the
fourth group was fed with probiotics in the presence of ethanol liquid diet.
Brain tissues: When the mice were treated for 4 weeks, they were sacrificed following
the protocol approved by the University of Tennessee Health Science Center (UTHSC)
Institutional Animal Care and Use Committee, and their brain sections were removed. The brain
tissue sections from the cerebral cortex region were then cryo-freeze and sectioned into 10µm
slices by using a cryostat.
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Staining for fluorescence confocal imaging: The different sections of the brain were
incubated with three different fluorescence agents: anti-GFAP antibody, anti-TMEM119
antibody, and DAPI according to standard protocols.
Confocal imaging: Brain cryosections (10μm thick) were fixed in acetone: methanol
(1:1) at −20°C for 2 min and the sections were rehydrated in PBS (137mM sodium chloride,
2.7mM potassium chloride, 10mM disodium hydrogen phosphate, and 1.8mM potassium
dihydrogen phosphate). The tissue sections were permeabilized with 0.2% Triton X-100 in PBS
for 10 min and blocked in 4% nonfat milk in Triton-Tris buffer (150mM sodium chloride
containing 10% Tween 20mM and 20mM Tris, pH 7.4). It was then incubated for 1 hour with the
primary antibodies (mouse monoclonal anti-Alexa Fluor 488-conjugated anti-GFAP and rabbit
polyclonal anti-TMEM119 antibodies), followed by incubation for 1 hour with secondary
antibodies Cy3-conjugated anti-rabbit IgG antibodies) and 10 min incubation with DAPI
(Hoechst 33342 dye). The fluorescence was examined using a Zeiss 710 confocal microscope
(Carl Zeiss GmbH, Jena, Germany) and images from x–y sections (1μm) were collected by LSM
5 Pascal software (Carl Zeiss Microscopy). Images were stacked by ImageJ software (Image
Processing and Analysis in Java; National Institutes of Health, USA) and processed by Adobe
Photoshop (Adobe Systems, USA). All the images for tissues from the different groups were
collected and processed under identical conditions.
IPR analyses: The IPR analyses were performed using a confocal image to quantify the
molecular-specific nano to microscale mass density fluctuations in the cells and nuclei, as
discussed above.
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4.3

Results
Confocal images of the mice's brain cortex tissues stained with different proteins/dyes

were obtained to study the effect of probiotics in chronic alcoholic glial cells and the chromatin
of the nuclei. Then the IPR analyses were performed on individual confocal images at 0.8 
0.8µm2 area, as described. The degree of disorder strength or <IPR> at each point at length
scales, L=0.8µm of cells, and molecular components of the mice brain cells were computed. On
average, 6 mice per group were considered, and at least 30 confocal micrographs for each
category: astrocytes, microglia, and the chromatin of mice brain cell nuclei were analyzed
separately. From these, the std of the ensemble average IPR values were calculated as obtained
in equations (4.2, 4.3). Finally, the computed (<IPR>) of astrocytes, microglia, and chromatin
of the mice's brain cells for ethanol-fed (EF), probiotics fed (PF+LP), and probiotics fed with
ethanol (EF+LP) were compared, relative to the control fed (PF) mice separately.
The intensity variation in the IPR images represents mass density fluctuations which
indicate the structural abnormalities present in different glial cells and the chromatin of mice
brain cell nuclei. In the IPR images, a higher mass density fluctuation is represented by the red
color, while the lower is represented by the blue color. As can be seen from the IPR images
(Figs. 4.1,4.3,4.5), the mass density or refractive index fluctuations increase in astrocytes and
microglia, and the chromatin of the brain cell nuclei when mice were treated with ethanol
indicates that alcohol altered the brain cells at the submicron scale. However, the slight increase
in the (<IPR>) value of the glial cells for mice fed with only probiotics might be due to the
interaction of probiotics with the gut cells/tissues blocking barrier dysfunction and endotoxemia
to some extent indirectly resulting in structural abnormalities in the brain. On the other hand,
when the mice were treated with both probiotics and ethanol simultaneously, the (<IPR>)
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reduced approximately back to normal or less than the normal in both cells and chromatin, which
suggest that probiotics function well in the presence of alcohol, preventing gut barrier
dysfunction and endotoxemia and results in an increase in the efficiency of brain functioning.
Therefore, probiotics such as L. Plantarum are considered good for brain health and help to
soothe and improve the cognitive function of the chronic alcoholic brain. The results are
systematically described below.
4.3.1

Structural alterations in astrocytes
Fig.4.1. (a)-(d) show the confocal image of astrocytes incubated with anti-GFAP

antibodies, while Fig.4.1 (a’)-(d’) are their corresponding IPR images, respectively. In Fig 4.2,
the bar graphs of relative change in the disorder strength (Ld) or (<IPR>) of brain astrocytes
cells of ethanol-fed (EF), probiotic fed (LP), and ethanol with probiotic fed (EF+LP) mice with
control fed (PF) mice are shown. As can be seen from Fig. 4.2, the relative study of (<IPR>) of
astrocyte brain cells increases when mice were fed with ethanol. In contrast, it significantly
decreases when mice were fed subsequently with probiotics and ethanol at the same time. It is
found that probiotics interact with the intestine, which indirectly affects the brain due to the GutMicrobiome-Brain axis and may increase the molecular spatial structural disorder of astrocytes
in the brain cells. Therefore, the (<IPR>) of astrocyte cells of mice fed with probiotics only
(PF+LP) is relatively higher compared to the PF. Although probiotics were believed to reduce
intestinal dysbiosis and enhance the gut-brain interaction, the result shows that probiotics may be
reactive to some specific components of gut cells and hence increase the mass density
fluctuations of the astrocytes. In particular, the bar graphs show that the (<IPR>) of astrocyte
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Figure 4.1

Confocal and IPR images of astrocytes.

Confocal and IPR images of astrocytes (PF, EF, PF+LP, EF+LP): (a)-(d) are the representative
confocal images of control (PF), ethanol fed (EF), probiotics fed (PF+LP), and ethanol and
probiotics fed (EF+LP) mice brain astrocytes cells while (a’)-(d’) are their corresponding IPR
images respectively at length scale L=0.8µm which are distinct. The IPR images show that the
molecular specific mass density fluctuation in astrocytes increases in the presence of ethanol as
well as probiotics, but when treated together, they decrease the density fluctuation due to alcohol
damage.
cells of EF mice increased by 280% relative to PF. This increase in the Ld or (<IPR>) implies
that ethanol-induced intestinal dysbiosis, which is a valid approach to dissect the gut-brain
interaction. This results in an adverse effect in the brain cells, especially in astrocytes, which
perform a variety of tasks such as axon guidance, maintenance of redox potential, regulation in
neurotransmitter and ion concentrations, synaptic support, blood flow control, removal of toxins,
and debris from the cerebrospinal fluid, etc. [119]. Astrocytes, the most numerous cells within
the CNS of the brain and can easily be exposed to alcohol. Therefore, chronic alcoholism may
exacerbate neuronal dysfunction and advances mechanisms in potentiating or nullifying the
pathway of neuropathologic injury [120]. However, the (<IPR>) of astrocyte cells decreases
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by 100% relative to EF when the mice were fed with probiotics and ethanol at the same time.
This decrease in the (<IPR>) of astrocytes cell of EF+LP supports that probiotics in the
presence of ethanol are highly efficient and blocked alcohol-induced gut barrier dysfunction and
endotoxemia, which are indirectly good for brain cells and maintain proper brain functions.

Figure 4.2

Bar graph representation of relative change in the disorder strength in astrocytes.

Bar graph for the relative values of molecular specific light localization property quantified as
(<IPR(L=0.8µm)>) or disorder strength (<IPR>~Ld) of astrocytes cells (total n~100 cells:
aroud~20 cells per micrographs, ~5 micrographs per mouse) of control (PF) mice compared to
ethanol fed (EF), probiotic fed (PF+LP), and ethanol and probiotics fed (EF+LP) mice. The IPR
analysis of astrocytes shows that the (<IPR>) or Ld~dn×lc of EF mice increased by 280%
relative to control. Also, the Ld value of astrocyte cells of PF+LP mice is relatively higher
compared to the control. This increase in mass density fluctuations indicates some effect of
probiotics on the astrocytes alone. However, the Ld value of astrocytes cells of EF+LP mice
decreases by 100% relative to EF mice which implies probiotics get stimulated with ethanol
decreasing the mass density fluctuations that are beneficial for brain cells. Student’s t-test
obtained p-value for EF is 0.004, PF+LP is 0.03, and EF+LP is 0.001 compared to PF. (P-values
<0.05).
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4.3.2

Structural alterations in microglia

Figure 4.3

Confocal and IPR images of microglia

Confocal and IPR images of microglia (PF, EF, PF+LP, EF+LP): (a)-(d) are the representative
confocal images of control (PF), ethanol fed (EF), probiotics fed (PF+LP), and ethanol and
probiotics fed (EF+LP) of mice brain microglia cells while (a’)-(d’) are their respective IPR
images at sample length L=0.8µm. The IPR images are distinct from the confocal images and
show that the molecular-specific mass density fluctuations increase in the microglia brain cells in
the presence of ethanol. Then the density fluctuation decreases when fed with ethanol and
probiotics simultaneously.

Fig. 4.3. (a)-(d), shows the confocal image of microglia incubated with the antiTMEM119 transmembrane protein antibody. Fig.3. (a’)-(d’) are their corresponding IPR images,
respectively. Fig. 4.4, the bar graphs of relative change in the disorder strength (Ld) or (<IPR>)
of microglial cells of control fed (PF) mice with ethanol-fed (EF), probiotic-fed (LP), and
ethanol and probiotic-fed (EF+LP) are shown. Fig. 4.3 represents the confocal images and IPR
images of the microglia cells, where IPR images are highly distinct from confocal images. The
bar graph presented in Fig. 4.4 indicates the effect of ethanol and probiotics in mice brain
73

Figure 4.4

Bar graph representation of relative change in the disorder strength in Microglia.

Bar graph for the relative study of molecular specific light localization property quantified as
(<IPR(L=0.8µm)>) or disorder strength (<IPR>~Ld) of microglia cells (total n~100 cells:
around ~20 cells per micrographs and ~5 micrographs per mouse) of control (PF) mice compared
to ethanol fed (EF), probiotic fed (PF+LP), and ethanol and probiotics fed (EF+LP) mice. The
IPR analysis of microglia shows that the (<IPR>) or Ld of EF mice increase by 120% in
reference to PF mice. The Ld value of microglia cells of PF+LP mice is relatively higher than the
control. This increase in mass density fluctuations represents some effect of probiotics in brain
microglial cells. However, the Ld value of microglial cells of mice fed with EF+LP decreases by
100% relative to EF mice which implies ethanol stimulates probiotics resulting in a decrease in
the mass density fluctuations that helps in soothing the brain cells. Student’s t-test obtained pvalue for EF is 0.009, PF+LP is 0.03, and EF+LP is 0.01 compared to PF. (P-values <0.05).

microglial cells based on the IPR analysis and shows a relative study induces changes in gut
microbiota, and as a result of gut-brain interaction it may mitigate of mice for EF, PF+LP, and
EF+LP with PF. The IPR analysis performed at the same sample length of all cases shows that
the (<IPR>) of EF mice increases by 120% relative to PF. This increase in the disorder
strength of microglia brain cells of EF mice suggests that alcohol neuroinflammation, destroying
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the microglial cells or immune system of the brain. Microglia are considered as the macrophages
of the CNS that clean up the cellular debris and participate in neuroinflammation to various
intrinsic and extrinsic stimuli. In addition to well-established phagocytic function and innate
immune function, microglia are involved in the development of CNS immunopathology [121]. It
was founded that alcohol enhances immunomodulatory molecules such as corticosterone and
endotoxin, which degrade the neuroimmune cells of the brain and selectively modulate the
intracellular signal transductions of microglia [122]. Also, the IPR analysis shows that the

(<IPR>) of microglial cells of mice fed with only probiotics (PF+LP) is relatively higher than
PF. This higher disorder strength might be due to probiotics interacting with mice gut
cells/tissues differently which results in microglia cells being more aggressive with the increase
in mass density fluctuations. Therefore, probiotics used to soothe and strengthen the cognitive
function of the brain may sometimes be reactive to the neuroimmune system of the brain cells,
but we have yet to study this in detail. On the other hand, the (<IPR>) of microglial brain cells
of mice fed with alcohol and probiotics simultaneously decreases by 100% relative to EF. This
implies alcohol stimulates probiotics and blocked the ethanol-induced gut barrier dysfunction,
endotoxemia, and liver damage resulting in increasing the efficacy of brain function and hence,
reducing density fluctuations and in turn, decreasing the disorder strength (Ld) of microglia of
brain cells. Therefore, this promising result suggests that probiotics with alcohol are good for
brain cells and enhance the development of CNS immunopathology.
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4.3.3

Structural alterations in chromatin

Figure 4.5

Confocal and IPR images of chromatin

Confocal and IPR images of chromatin of brain cells (PF, EF, PF+LP, EF+LP): (a)-(d) are the
representative confocal images of control (PF), ethanol fed (EF), probiotics fed (PF+LP), and
ethanol and probiotics fed (EF+LP) while (a’)-(d’) are their respective IPR images of chromatin
of mice brain cells at the sample length L=0.8µm. The IPR images are distinct from the confocal
images and show that the molecular specific mass density fluctuation increases in the chromatin
of mice brain cell nuclei in the presence of ethanol which decreases when they were fed with
alcohol and probiotics simultaneously.
Fig.4.5. (a)-(d) show the confocal images of brain cell nuclei incubated with DAPI, while
Fig. 4.5. (a’)-(d’) are their corresponding IPR images, respectively. In Fig. 4.6, the bar graphs
relative change in the disorder strength (Ld) or (<IPR>) of nuclei in the brain cell of control
(PF) mice with ethanol fed (EF), probiotic-fed (LP), and ethanol and probiotic-fed (EF+LP) are
shown. The molecular-specific IPR analysis of DAPI stained confocal images of mice brain cell
nuclei at sample length, L=0.8µm indicates that the mass density fluctuations or (<IPR>) of EF
mice increases by 25% relative to PF. This is because of chronic alcohol-induced intestinal
mucosal barrier dysfunction in the gut, which as a result induces an adverse effect in the brain
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due to gut-brain interaction. This adverse effect is in some way related to an increase in
submicron scale mass density fluctuation or the (<IPR>) in the chromatin of EF mice brain
cells. Hence, the rise in DNA mass density fluctuations of the chromatin due to alcohol is
responsible for an increase in the degree of disorder strength (Ld). Persistent alterations to the
chromatin structure are factors for epigenetics inheritance and can have a long-lasting influence
on the activity and connectivity functions of the brain [123]. The (<IPR>) of chromatin in the
brain cell nuclei of mice fed with only probiotics (PF+LP) is relatively lower compared to the
PF, indicating that probiotics are good for the mice digestive system that is correlated with
soothing and well-functioning of the brain especially in chromatin of nuclei. Further, the

(<IPR>) value of chromatin in brain nuclei of mice fed with alcohol and probiotics at the same
time decreases by 40% relative to PF. This decrease in the (<IPR>) of the chromatin of mice
cell nuclei fed with alcohol and probiotics at the same time is because probiotics in the presence
of ethanol get highly stimulated and attenuate alcohol-induced intestinal mucosal barrier
dysfunction, which is good for the chromatin of the brain cell nuclei and allow the brain to
soothe and function better.
The molecular-specific structural quantification of probiotic's effect on alcoholic brain
cells using the confocal image and IPR analyses shows that alcohol affects the digestive system,
which indirectly damages the glial cells and the chromatin of the nuclei of the brain cells. We
speculate that the gut-brain interaction associated with these findings involves endotoxin
absorption due to intestinal barrier dysfunction and gut dysbiosis. The probiotic, L. Plantarum by
itself caused a small increase in the degree in the disorder strength or (<IPR>) of astrocytes
and microglia cells while a decrease in the chromatin of the brain cells. However, the obtained
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result strongly supports that the probiotics L. Plantarum feeding very effectively blocked
alcohol-induced changes in astrocytes and microglia.

Figure 4.6

Bar graph representation of relative change in the disorder strength of chromatin.

Bar graph for the relative study of molecular specific light localization property quantified as
(<IPR(L=0.8µm)>) or disorder strength (<IPR>~Ld) of chromatin in nuclei (total cells n~400,
around ~80 cells per micrographs and ~5 micrographs per mouse) of control (PF) mice
concerning to ethanol fed (EF), probiotic fed (PF+LP), and ethanol and probiotics fed (EF+LP)
mice. The IPR analysis of chromatin of the mice brain cells shows that the (<IPR>) or Ld of EF
mice increases by 25% relative to control. The Ld value of chromatin in nuclei of mice fed with
PF+LP is relatively lower compared to the control. This decrease in mass density fluctuations
represents some effect of probiotics in chromatin of the brain cell nuclei. However, the Ld value
of chromatin of mice brain cell nuclei fed with EF+LP decreases by 40% relative to PF mice due
to the decrease in mass density fluctuations which implies probiotics in the presence of ethanol is
more active and help in soothing the brain function. Student’s t-test obtained p-value for EF is
0.01, PF+LP is 0.002, and EF+LP is 0.007 compared to PF. (P-values <0.05).

4.4

Conclusions
The molecular-specific light localization technique, IPR, is used to study the effect of

probiotics in chronic alcoholism in glial cells, astrocytes, and microglia, and the chromatin of
brain cell nuclei using a confocal image and a mouse model. Changes in the molecular specific
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structural disorder were probed for: (i) upregulation of type III intermediate protein spatial mass
density in astrocytes, (ii) upregulation of transmembrane protein anti-TMEM119 spatial mass
density in microglia, and (iii) rearrangements of DNA mass density in nuclei of neural cells. The
submicron scale mass density fluctuations quantified as the std of average IPR or (<IPR>)~Ld
using a confocal image show an increase in disorder strength (Ld) of the molecular specific
probing of astrocytes and microglia cells, as well as the chromatin of brain cell nuclei of alcoholtreated mice. This increase in the disorder strength or mass density fluctuations in brain glial
cells and chromatin is due to gut-brain interaction confirms alcohol-induced gut barrier
dysfunction, endotoxemia, and liver damage and eventually leads to neuroinflammation,
especially in glial cells and the chromatin of brain cell nuclei due to gut-brain interaction. On the
other hand, probiotics fed control mice have a small increment in the disorder strength of brain
glial cells, which may be due to the interaction of probiotics, L. Plantarum in gut cells/tissues
differently increasing mass density fluctuations. Therefore, the Ld value increases in the
astrocytes and microglia cells when fed with only probiotics invite a detailed study to elucidate
plausible reasons for an adverse effect of L. Plantarum in glial cells, although probiotics are
considered reasonable and used to improve the cognitive function of the brain. Interestingly, a
decrease in the Ld value in glial cells and the chromatin of brain cell nuclei fed with ethanol and
probiotics simultaneously relative to control and ethanol fed mice indicate that L. Plantarum in
the presence of alcohol gets highly stimulated and increase the efficacy and well-functioning of
the brain. That means, these probiotics first increase the efficacy of the digestive system and as a
result of gut-brain interaction, which indirectly helps in soothing the brain's physical structure
and enhances the multifunctionality of the brain. Therefore, this almost reversible effect of
probiotics when it is given with the alcohol on the brain cells/components could be one of the
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ways to mitigate neurological abnormalities in the brain cells due to alcohol or any other drug.
As an illustration of the potential application of the recently developed mesoscopic physicsbased molecular-specific IPR technique via confocal imaging, we have successfully quantified
probiotic effects on glial cells and chromatin of the brain cell nuclei based on the structural
abnormalities present in brain cells/tissues.
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CHAPTER V
QUANTIFICATION OF NANOSCALE STRUCTURAL ALTERATIONS IN OVARIAN
CANCER CELLS TO STUDY ANTI-CANCEROUS DRUG EFFECT USING TEM-IPR
This chapter is adapted from the author’s published article with copyright permission
from the publisher. Ref [57] P. Adhikari et. al., "Studying nanoscale structural alterations in
cancer cells to evaluate ovarian cancer drug treatment, using transmission electron microscopy
imaging," Physical Biology 17(3), 036005 (2020).
Although, the main probing technique in this dissertation is optics/photonics that are
within the diffraction limit (resolution ~200nm). However, it would be interesting to see the
properties of the cell at nanoscale resolution, that can support the optical techniques. In this
chapter, we have used TEM imaging to probe the structural disorder below 100nm and studies
the effects of anti-cancerous drugs on ovarian cancer cells.
Anti-cancerous therapies are intended for the growth inhibition of cancer cells which are
initially at the nanoscale level; however, it is challenging to detect the efficacy of such drugs in
the early stages of treatment. A unique method to assess the impact of anti-cancerous drugs on
cancerous cells/tissues is to probe the nanoscale structural alterations. For this, TEM imaging on
thin cell sections is performed to obtain their nanoscale structures where we can probe up to 1nm
structure. In this work, we apply the IPR technique in TEM imaging (TEM-IPR) to study the
effect of different anti-cancerous drugs on ovarian tumorigenic cells, using their nanoscale
structural alterations as a biomarker. Based on the degree of disorder strength the efficacy of the
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anti-cancerous drug and level of tumorigenicity are quantified. Hence the potential applications
of the technique for cancer treatment and diagnosis are discussed.
5.1
5.1.1

Introduction
Why TEM imaging and probing nanoscale changes in cancer?
TEM imaging is a method where we can probe ~1nm resolution within the sample, and

this has been used for imaging of cells at the nanoscale to see the inner structures of the cells, in
general, qualitatively. It has been established that cancer progression is associated with the
nanoscale structural alteration in a cell due to rearrangements of the building blocks of the cell
such as DNA, RNA, and lipids. Therefore, TEM imaging with spatial nano-resolution is a good
modality to look at the nanoscale cell structures and measure cancerous changes in cells at the
nanoscales.
The structural alterations in cells have been characterized by visible-light microscopy
techniques within the diffraction limit. For example, the newly developed spectroscopic
microscopy technique has shown success in probing these alterations to some degree that are
prominent in early carcinogenesis [16,17,58,124–126], and these nano morphologies are
associated with the basic cellular building blocks. Therefore, TEM imaging is a good modality to
probe cancerous changes in cells at the nanoscale level, very much beyond the diffraction limit
of light. The details of the TEM schematics and application in scientific research are explained in
Chapter I Section 1.2.1. Furthermore, the recently developed light wave localization technique,
IPR using TEM imaging, has shown success in quantifying the degree of structural changes in
one parameter, known as the degree of the structural disorder [22,23]. In particular, using the
IPR method, a TEM image is used to construct a disordered 2D mass matrix, and from this, we
generate a 2D refractive index matrix. Optical waves are then solved for their eigenvalues and
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eigenfunctions using the refractive index matrix with closed boundary conditions. The light
localization properties are measured by the average inverse participation ratio, <IPR>, and
standard deviation of the IPR, σ(<IPR(L)>)cells, of the eigenfunctions of the light waves in these
samples. It is shown that the degree of structural disorder is proportional to the <IPR> or
σ(<IPR(L)>)cells [32,33]. Therefore, the <IPR> can be used as a measure of the degree of
nanoscale structural disorder, and to monitor structural change in cells under diseases condition.
The IPR method is a very versatile approach. The IPR method, using TEM imaging, has been
recently generalized to study the structural changes in brain and colon cells in chronic
alcoholism [127,128]. Furthermore, the IPR method also extended to study the molecular
specific (DNA, histone, etc.) structural changes in cells by using molecular-specific fluorophores
and confocal microscopy imaging [38,83].
5.1.2

Ovarian cancer study
Ovarian cancer (OC) ranks 5th in cancer-related deaths among women and accounts for

more deaths than any other cancer of the female reproductive system. The American Cancer
Society (ACS) estimated new cases of OC in the USA in 2019 would be 22,530, whereas
estimated deaths would be 14,000. Most OC cases are diagnosed at a very late stage, of which
51% are diagnosed as stage III and 29% are diagnosed as stage IV [129]. The exact cause that
triggers OC is not clearly understood but there are several risk factors such as fertility therapy,
late pregnancy, family history, hormone therapy after menopause, etc. are associated with the
development of OC. Metabolic alterations, suppression of tumor suppressor genes, and
oncogenic activations are also considered as triggering factors for OC initiation and progression
of the disease [130,131]. Although initially sensitive to chemotherapy treatment, however, the
majority of OC patients develop chemoresistance. 10 years survival rate for most patients of all
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stages of OC is ~30%. Development of chemoresistance, widespread disease during the time of
diagnosis, and tumor recurrence are the major challenges in the therapeutics of ovarian
cancer [132].
In this study, we are focusing on analyzing the impact of novel anti-cancerous drug
treatment in the tumor forming OC cell line in vitro. HSulf-1 knockdown OV202 cells are
selected for this study for their aggressive tumor forming ability and high proliferation
rate [133,134]. This method of analysis is aimed to understand the effect of anti-cancerous drugs
on cells in the early phases of treatment. Here we propose a novel TEM-IPR approach to assess
the impact of anti-cancerous drugs in cancerous cells by quantifying the degree of nanoscale
structural disorder.
5.2
5.2.1

Methods
IPR technique using TEM images
TEM experiment has a resolution of ~1nm and can identify the nanoscale architectural

alterations inside the cells which take place in normal cells when affected by cancer. These
nanoscale alterations happen in the cells due to the rearrangement of the basic building blocks of
the cells, such as DNA, RNA, lipids, macromolecules, etc. This results in mass density
fluctuations in the cells. Using a thin slice of a cell (~100nm), the mass density variations can be
probed by TEM imaging. The detail of the TEM schematic and imaging is presented in Chapter I
Section 1.2.1. The IPR calculation is an efficient technique to measure and quantify the
cancerous level of aggressiveness in a cell through its mass density fluctuations. A higher
<<IPR(L)>> or σ(<IPR(L)>) value indicates an increasing amount of the nanoscale mass
density fluctuations in cells. The IPR technique is described in detail in Chapter I Section
1.2.3 [22,23,32,33]. However, we will describe the IPR technique using TEM images in brief.
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The refractive index of a thin cell slice at a point n(x,y) can be written as n(x,y) =
no+dn(x,y), where no is the average refractive index and dn(x,y) is the fluctuation of refractive
index at (x,y) indicated voxel. In the thin sample, a voxel of area dxdy at position (x,y) and
thickness dz, the transmission TEM intensity: ITEM(x,y)=I0-I0αd(z), where α is a transmission
related constant depends on the mass of the voxel as shown in Chapter I Section 1.2.3. TEM
image intensity at any voxel point (x,y) for a thin cell sample can be expressed as ITEM(x,y) =
I0TEM + dITEM(x,y), where I0TEM is the average pixel intensity and dITEM(x,y) is the fluctuation part
of the pixel intensity. Here, the intensity fluctuation ITEM(x,y) < I0TEM (average intensity), where
I0TEM=<I(x,y)>(x,y) and dITEM(x,y)=ITEM(x,y) - <I(x,y)>(x,y) and dn(x,y) < n0.
Therefore, the intensity of a TEM image is linearly proportional to the mass, M, and
refractive index, n of the voxel as shown in Chapter I equation (1.10, 1.11), except ITEM is the
intensity of the TEM image. From this, we can calculate the optical potential of the voxel point
as εi(x,y) obtained in Chapter I equation (1.12) to generate an optical lattice.
Knowing the optical potential at every point, the Anderson disordered tight-binding model TBM
Hamiltonian [28,30,118] can be obtained as in Chapter I equation (1.13) for the TEM closed
system. For a sample size of length L in the TEM image, we have L×L sample area in the TEM
image. We calculate the average IPR at length L where L=NL×dx (dx=dy). As there are
N=NL×NL numbers of lattice points, thus, there will be N eigenvalues, as well as the same
number of eigenvectors. Finally, the average IPR value of the sample of length L or size L×L is
defined as [22,23,32,33,46,47]:
𝑁

𝐿 𝐿
1
< 𝐼𝑃𝑅 >𝑁 = ∑ ∫ ∫ 𝐸𝑖4 (𝑥, 𝑦)𝑑𝑥𝑑𝑦,
𝑁
0 0
𝑖=1
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(5.1)

where Ei denotes the i-th eigenfunction of the Hamiltonian, N is the total number of potential
points on the refractive index matrix (i.e., N=(L/dx)2). It has been shown that the ensembleaveraged IPR value (i.e., ensemble-averaged of similar type of cells): <<IPR(L)>> =
<<IPR(L)>L×L> or (<IPR(L)>, is proportional to the degree of structural disorder Ld. Then,
⟨𝐼𝑃𝑅⟩ ≡< 𝐼𝑃𝑅 >𝑒𝑛𝑠𝑒𝑚𝑏𝑙𝑒 ~ 𝐿𝑑 = 𝑑𝑛 × 𝑙𝑐 ,

(5.2)

(< 𝐼𝑃𝑅 >) ≡ (< 𝐼𝑃𝑅 >)𝑒𝑛𝑠𝑒𝑚𝑏𝑙𝑒 ~ 𝐿𝑑 = 𝑑𝑛 × 𝑙𝑐 .
(5.3)
Equation (5.1) presents the average value of one IPR pixel at length (L) that is
constructed from the L×L TEM area or N pixels of the TEM image. Our statistical analysis
involves calculating the average and standard deviation of the disorder strength of IPR values,
i.e. Ld values over the cell samples for the length of a given sample. Using this structural disorder
strength <<IPR(L)>> or (<IPR(L)>) or Ld as a biomarker, we study the structural properties of
ovarian cancer cells with anti-cancerous drug treatments.
5.2.2
5.2.2.1

Sample preparation and TEM imaging
Ovarian normal and cancer cell lines
OV202 cell line is a low-passage primary ovarian cancer cell line established at the Mayo

Clinic [133]. OV202 NTC (expressing HSulf-1) and Sh1 cells (HSulf-1 deficient) are developed
by Dr. Shridhar’s group at Mayo Clinic and are described earlier elsewhere [134]. Subcutaneous
injection of OV202 Sh1 cells resulted in tumor formation in nude mice, whereas HSulf-1
expressing OV202 NTC cells did not form tumors [133]. Both cells were grown in minimum
essential medium alpha 1X (Cellgro) supplemented with 20% fetal bovine serum (Biowest) and
1% penicillin-streptomycin (Cellgro). All cells were grown in the presence of 1 μg/ml puromycin
as a selection marker for the HSulf-1 shRNA cells were treated with 10 µl of AACOCF3 or
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MAFP (cPLA2 inhibitors; Cayman chemicals) for 24 hours. Following this treatment, cells were
washed twice with PBS and then fixed in Trump’s fixative containing 4% formaldehyde and 1%
glutaraldehyde in phosphate buffer pH ~7.3, post-fixed in 1.0% OsO4, dehydrated with ethanol
gradation, and transitioned into propylene oxide for infiltration and embedding into super epoxy
resin.
5.2.2.2

TEM imaging
Cell samples were fixed in Trump’s fixative (pH 7.2) at 4°C overnight, spun down and

the supernatant removed. They were re-suspended in agarose which was cooled and solidified.
The cells in agarose were then post-fixed in 1% OsO4, dehydrated through a graded series of
ethanol, and embedded in Spurr resin. 100nm (or 0.1μm) ultra-thin sections were mounted on
200-mesh copper grids, post-stained with lead citrate, and observed under a JEOL JEM-1400
transmission electron microscope at 80kV.
5.3

Results and discussions
The TEM images of the ovarian cancer cells are obtained as described in the above

section. IPR analyses were performed for the samples on different length scales of TEM images.
The IPR averaging of a sample length L, <<IPR(L)>> over a single cell, then over the different
cells, was performed for obtaining the ensemble averaging: <<IPR(L)>>=<<IPR(L)>L×L>. As
discussed above, the <<IPR(L)>> value for each TEM image was calculated and provides the
degree of the structural disorder strength at a defined length scale L.
Fig. 5.1(a)-(d) are the representative grayscale TEM images of a thin section (~100nm) of
a cell from the following ovarian control/cancer cell lines: (i) non-tumorous NTC, (ii) tumorous
Sh1, (iii) Sh1 treated with drug AACOCF3 (Sh1-AACOCF3), and (iv) Sh1 treated with drug
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MAPF (Sh1-MAFP). For each case (i.e. for a particular cell line) study, 8 different cells were
taken from the cell line for averaging. Figure 5.1(a’)-(d’) are the corresponding (<IPR(L)>)
images of Fig. 5.1(a)-(d), at a length scale of 165nm and sample size of 165165nm2. It is
reported that structural alteration in carcinogenesis happens around sample length L~100nm or
sample size LL [127], which is around the basic building blocks of the cell. Therefore, we have
taken a length scale of 165nm which is higher than 100nm. For a better understanding of the IPR
images at different length scales, we have also added IPR images at two different length scales
(one 82nm <100nm and another 206nm>100 and 165nm), in the Supplementary Documents. As
can be seen from Figure 5.1, σ(<IPR(L)>) images represent different intensities of disorder
patterns in the cell line which are distinct from conventional grayscale TEM images. In the IPR
images, intensities patterns of higher fluctuations in the cells are represented by the red spots and
lower intensities with blue. In the figure, it can be seen that the increasing fluctuation or

(<IPR(L)>) value increases from the less proliferating NTC cells to highly proliferating Sh1
cells and decreasing of the fluctuations or (<IPR(L)>) values decrease with the treatment of
two different anti-cancerous drugs, AACOCF3 and MAFP. The drug effect can be distinctly
visualized in the IPR images.
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Figure 5.1

TEM and IPR images of anti-cancerous drugs treated ovarian cancer cells.

(a)-(d) are the TEM images and (a’)-(d’) are their respective IPR images at the sample length
(LL=165165nm2) from ovarian cells of the following: non-tumorous (OV202 NTC); tumorous (OV202
Sh1); AACOCF3 treated tumorous Sh1, Sh1-AACOCF3; and MAFP treated tumorous Sh1 Sh1-MAFP.
IPR images are distinct from the TEM images.

TEM images and their corresponding IPR images for representative ovarian cancer cases
(NTC, Sh1, Sh1-AACOCF3, and Sh1-MAFP) at two different sample lengths: one 82nm
<100nm or 165nm and another 206nm>100nm or 165nm, are presented for the better
clarification. It has been reported that structural changes are significant around 100nm and in this
particular experiment as seen from Fig. 5.2 prominent changes start around 150nm. Therefore,
we have taken sample length 165nm to study the anti-cancerous drug effect in ovarian cancer
cells. Here, from the presented IPR image at different length scales it can be seen that IPR
images show more fluctuations above ~100nm and lower for smaller length scales.
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Figure 5.2

TEM and IPR images of ovarian cancer cells at different length scales.

(a)-(d) are the TEM images, while (a’)-(d’), and (a’’)-(b’’) are their respective IPR images at the
2

2

sample length (L) [LL=8282nm , and LL=206206nm ] below and above the presented IPR
image at sample length, L = 165nm respectively from ovarian cells of the following: nontumorous (OV202 NTC); tumorous (OV202 Sh1); AACOCF3 treated tumorous Sh1, ShAACOCF3; and MAFP treated tumorous Sh1 Sh1-MAFP. IPR images are distinct from the TEM
images.

Fig. 5.3 shows the length (L) dependent fluctuations with the sample size (L×L). We
plotted, variations of the standard deviation (<IPR(L)>) vs L with the increase of sample
lengths: L = 41, 82, 123, 165, 206, 247, 288 nm. As the deviation started appearing in the mean
and STD of <IPR(L)>L×L, at L=100nm, therefore we have plotted the σ(<IPR(L)>) vs L,
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systematically well below and above 100nm. These lengths are for the cells from the following
cell lines: non-tumorigenic (OV202 NTC); tumorigenic (OV202 Sh1); AACOCF3 treated
tumorigenic Sh1 (Sh1-AACOCF3); and MAFP treated tumorous Sh1 (Sh1-MAFP). As can be
seen from the figure that the deviation in the degree of nano-fluctuations between nontumorigenic cells NCT and tumorigenic cells Sh1 started becoming prominent around the length
scale ~100nm. Interestingly, the degree of nano-fluctuations of anti-cancerous drugs treated Sh1
tumorigenic cells reverse to that of the non-tumorigenic NTC cells. This confirms the efficacy of
these two anti-cancerous drugs.

Figure 5.3

Sample length scale (L) dependence of σ(<IPR(L)>).

Variations of the standard deviation σ(<IPR(L)>) with the increase of sample length L, for cell
lines non-tumorigenic (OV202 NTC); tumorigenic (OV202 Sh1); AACOCF3 treated tumorigenic
Sh1 (Sh1-AACOCF3); and MAFP treated tumorous Sh1 (Sh1-MAFP). It can be seen that the
deviation between NTC and Sh1 started to become prominent around the sample length/length
scale ~100nm. Interestingly, the drug-treated Sh1 tumorigenic cells' fluctuation degrees reverse to
the non-tumorigenic cells.
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Figure 5.4

Bar graph representation of anti-cancerous drug-treated ovarian cancer cells

Bar graph representation of the standard deviation of the degree of structural disorder strength Ld
~σ(<IPR(L)>) calculated from the TEM images for: non-tumorous (NTC), tumorous (Sh1),
AACOCF3 treated tumorous cells Sh1-AACOCF3, and MAFP treated tumorous cells Sh12

MAFP. For the normal cells, IPR analysis was performed at the sample size 165×165nm . The
result shows Ld value increases from non-tumorous to tumorous cells, then it decreases when
these tumorous cells are further treated with anti-cancerous drugs AACOCF3 and MAFP,
interestingly the Ld value returns almost back to the same value of the non-tumorous cells (pvalues < .05). This may imply that anti-cancerous drugs are working well in ovarian cancer
treatment.
Figure 5.4 presents the bar graphs of the standard deviation of calculated (<IPR>) or
(Ld) value, of the ovarian cells at the fixed-length scale of 165nm. The variations are similar at
lower sample length scales >165nm, however, we have chosen 165nm to show a prominent
difference. Statistically, the standard deviation is the more reliable marker than the average, as it
only depends on the width of the distribution, irrespective of the mean position. The result shows
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the standard deviation of the degree of structural disorder (<IPR>) value increased by 70%
from NTC to Sh1 cells. Furthermore, when Sh1 cells were treated with 2 different anti-cancerous
drugs, AACOCF3 and MAFP, the (<IPR>) values decreased by around 58% for AACOCF3
and 54% for MAFP, relative to the (<IPR>) value of the Sh1 tumorous cells. In particular, with
the treatment of the anti-cancerous drug, the structural biomarker parameter (<IPR>) or Ld
value decreased nearly back to the normal value. The normalcy detection of these anti-cancerous
drug-treated cancerous cells may require further investigations using different modalities. It has
been earlier shown that AACOCF3 is a better anti-cancerous agent producing more anticancerous effects in OC cells compared to MAFP [135]. It can be seen in Fig. 5.4 that similar
trend of bar graphs which show a reduction in the degree of structural disorder (<IPR>) value
for AACOCF3 (58%) > MAFP (54%), consistent with the known qualities of the drugs, in this
length scale. Hence, the quantitative analysis technique, called IPR, quantifies the nanoscale
structural disorder (<IPR>) or Ld, as an important biomarker to study the structural alterations
at the nanoscale level and has the potential to detect the effect of anti-cancerous drugs in
carcinogenesis ovarian cancer.
5.4

Conclusions
The nanoscale mass-density fluctuations are quantified with the progression of ovarian

carcinogenesis, as well as the effects of two anti-cancerous drugs on non-tumor forming
OV202NTC and tumor forming OV202Sh1 cells are studied using the TEM imaging and IPR
technique. TEM experiment has a resolution of ~1nm and can identify the nanoscale
architectural alterations inside the cells which take place in normal cells due to the rearrangement
of the very basic building blocks of the cells, such as DNA, RNA, lipids, macromolecules, etc.
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This results in nanoscale mass density fluctuations in the cells which can be probe using TEM
imaging. The nanoscale fluctuations are quantified by the STD value of the <IPR(L)>L×L,

(<IPR(L)>)cell, performed over similar types of cells or ensembles of the samples. Results show
an increase in the nanoscale fluctuations or (<IPR(L)>) value from non-tumorous NTC to
tumorous Sh1 cells. The (<IPR(L)>) values for two different drugs treated tumorous cells, Sh1AACOCF3 and Sh1-MAFP, have reduced value from tumorous cells Sh1 and the reduced values
are nearly the same to the NTC non-tumorous cells. Earlier IPR analysis of a different cell line
has verified the increase of nanoscale structural disorder with the progression of cancer [22,23].
Based on the results presented, we investigate the potential applications of the IPR technique in
measuring and quantifying the effectiveness of different anti-cancerous drugs on ovarian cancer
treatment. This quantification of the effectiveness of anti-cancerous drugs in ovarian cancer
treatment could enhance better drug treatment modalities at their earliest and helps to control the
deadly ovarian cancer. Although this study is based on ovarian cancer cells, however, the
technique can be applied to the varieties of cancers to assess the effectiveness of different anticancerous drugs in treatment.
Our technique is based on the linear transmission of the TEM intensity through thin cell
samples as described in the Method. The TEM intensity transmits well till ~500nm of thin cell
samples, the technique works until that thickness of the samples. Because of the thin sample, this
method can be applied to heterogeneous cell samples.
A cell is around 5 microns thick, and the TEM sample thickness is around 100nm,
therefore, 50 TEM slices per cell can be generated. Thus, it is important to consider ensemble
averaging correctly by choosing similar types of TEM micrographs. For each cell, TEM
micrographs are chosen around the middle of the cell by observing the maximum size of the
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nucleus. The maximum changes in a cancerous cell can be captured by considering the largest
portion of the cell or nucleus. Not considering proper ensemble averaging, results may vary.
At present, the super-resolution optical microscopy techniques have achieved an order of 5-10nm
resolutions targeting particular types of molecules in a cell [136–138]. However, in the case of
TEM imaging, we can target whole cells or nuclei with ~1nm resolution. This nanoscale
resolution brings advantages of the TEM imaging for the quantification of structural disorder and
its alterations at submicron to nanoscales in the nucleus/cell, in progressive carcinogenesis, or
any other cell abnormalities. It would be interesting to compare the results of TEM-IPR analysis
with the super-resolution microscopy in progressive carcinogenesis or abnormalities of a cell, in
a near future.
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CHAPTER VI
CONCLUSIONS AND FUTURE WORK
The elastic light scattering signal from cells/tissues can be recorded after propagating
through the cells/tissues which carries tremendous information useful for cancer diagnosis and to
study drug effects in cancer treatment or any other abnormalities. The 1D backscattered signals
are sensitive to refractive index fluctuations at any length scale including way below the
wavelength range. Furthermore, we have studied molecular-specific light localization techniques
using TEM and confocal imaging, a powerful method to quantify molecular-specific changes in
the mass density of refractive index fluctuation in cells/tissues. In this dissertation, using both
PWS (open scattering) and IPR (close scattering) techniques, we probe the structural alteration of
the cells/tissues and quantify the degree of structural disorder to study cancer stages, drug effects
in cancer treatment, and chronic alcoholic brain abnormalities.
With the addition of finer focusing using a highly sensitive 3D motorized scanning stage
in the developed PWS technique (resolution ~40nm), we have shown that these backscattered
signals from cells/tissues are sensitive to refractive index fluctuations below the wavelength
within the diffraction limit and can distinguish the stages of progressive cancer in TMA. The
result also demonstrates that the use of low NA illumination prevents interference between the
1D adjacent channels, increasing the sensitivity of the technique to nanoscale refractive index
fluctuations. Likewise, the PWS quantification of 3D structure tumor developed from cancer
cells 2D structure reflects the unique ability of PWS to study the anti-cancerous drug effect in
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cancer treatment. On the other hand, we quantify refractive index or mass density fluctuations in
a closed weakly disordered heterogeneous optical system based on light localization technique
using confocal and TEM imaging. In the case of carcinogenesis or any other abnormalities, DNA
molecules inside the cells undergo structural alteration due to the mass density variation and
rearrangements which result in the light wave eigenfunction localization. This results in nano to
microscale structural alteration which can be detected based on a molecular specific light
localization technique using a confocal image as demonstrated by quantifying probiotic effect in
alcoholic brain cells. Our results also show that the TEM micrograph can be effectively used to
quantify the molecular specific mass density fluctuations in terms of the degree of disorder
strength using the IPR technique to detect carcinogenesis and drug effect in cancer treatment.
In this chapter, a summary of the developed spectroscopic systems, in a bid to elucidate
the promising applications of these techniques are reported. In addition to this near-future studies
and recommendations using these techniques are presented.
6.1

PWS study conclusions
The developed finer focusing mesoscopic physics-based imaging technique, PWS can

scatter precise scattering volume to detect minute structural changes in terms of the refractive
index fluctuations below the sub-diffraction length scale, within the diffraction limit. In this
dissertation, the finer focusing PWS technique was successfully used to quantify the degree of
disorder strength (Ld) and distinguished the stages of cancer in commercially available paraffinembedded deadly cancer TMAs. This result could help to standardized cancer diagnostic
modalities and use these samples to study the drug effect in cancer treatment. With the validation
of added finer focusing, our results demonstrate that PWS was able to differentiate different
stages of cancer, especially for paraffin-embedded pancreatic, breast, colon, and prostate cancer
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tissues. The PWS result shows that for each TMA cancer tissue, the degree of disorder strength
increases significantly with an increase in cancer stages for each cancer type supporting the fact
that mass density fluctuations or refractive index fluctuations increase in progressive cancer.
Lastly, the flexibility provided by the highly sensitive PWS technique and commercially
available TMA samples to distinguish the cancer stages opens a broad path to explore for
generalizing the structural changes in progressive cancer and drug effect for effective cancer
treatment/diagnosis.
In addition to this, the structural properties of tumors developed by the xenografting of
drug-sensitive and drug-resistive prostate cancer (PC) cell lines were quantified using the finer
focusing PWS technique. The results indicate that tumor tissues (3D model) grown by
xenografting PC cells (2D model) resistant toward docetaxel have a higher degree of disorder
strength (Ld) than drug-sensitive PC cells. Cancerous cells that survived through drug exposure
are more aggressive and develop different morphological structures resulting in higher mass
density fluctuation due to the rearrangement of macromolecules, large pore sizes, changes in
cytoskeleton nanoarchitecture. This result further concludes that xenografted tumors from the
drug-sensitive and drug-resistant PC cell lines maintain the same type of structural properties
when grown to 3D structures supporting a strong correlation in structural properties of cells
grown on 2D glass slide structure surfaces. Therefore, the PWS study of xenografted tumor 3D
structures that replicate the structural properties of cancer cells could be a reliable, easy, and
quantitative approach to diagnose chemo-resistance for the future. This promising result seeks an
application to monitor the effect of chemotherapy drugs on a different level of tumorigenicity by
both in-vitro and in-vivo analysis.
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6.2

Future work in PWS and its applications
The PWS microscopic setup developed in this work is highly sensitive, fast, and cost-

effective. The results obtained from the engineered PWS technique may have profound
biological and medical implications. In the fields of cancer biology and medicine, the PWS
technique could help us to understand the structural properties of cancerous cells/tissues as well
as chemotherapy or anti-cancerous drug effects in cancerous cells/tissues at the nanoscale level
which need to be explored in detail. Monitoring the growth of cancerous cells/tissues with or
without anti-cancerous drugs using the PWS technique and xenograft model for different types
of cancer could play a crucial role in cancer control in the coming days. The quantification of
structural changes in cells/tissues due to abnormalities such as radiation exposure, alcohol, stress,
etc. might also be interesting to study next with PWS. At this point, it may not be possible to
identify which specific structure is responsible for an increase in the degree of disorder strength
(Ld) and associated with molecular mechanism, however, we can have some insight into how
these nanoscale structural changes are associated with cancer progression and anti-cancerous
drug treatments. And the improvement in the construction of the disorder map or Ld map with the
reduced noise performance in the short interval of time could provide an opportunity to visualize
which part is specifically affected by the diseases. Further, the flexibility provided by the
spectroscopic technique using commercially available TMA samples to standardize the early
cancer diagnostic and study the drug effect in cancerous treatment opens exploration for
generalizing the structural change in progressive cancer for effective cancer treatment. With
these promising applications of PWS in biomedical implications, we want to move forward with
the PWS technique from clinical research to clinical trials especially to study drug-sensitive and
drug-resistive different cancer treatment cases.
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In addition to this, we can work on the PWS instrumentation to increase the sensitivity of
the system and make it more compatible with the in-hospital application. For this, we can use a
highly sensitive and compatible liquid crystal tunable filter with less than 1nm resolution and
replace the existing CCD camera with a low cooling effect and high quantum efficiency (QE)
CCD camera. Also, we can replace the existing 3D motorized scanning stage with a highly
sensitive stage for precise focusing within the working distance of the low NA objective. To
make this technique compatible with both in-vitro and in-vivo diagnostic we can replace the light
source and combination of lenses as mentioned in Chapter I Section 1.1.1 with optical fibers and
develop the system in a portable microscopic setup, that can be used in-vivo. We are planning to
modify the existing BX61 bright field microscope replacing the existing light source with an
optical fiber-based halogen lamp (100W) light source and mounting an LCTF filter coupled with
a Retiga 3 CCD camera on the top of a microscope to capture the spectroscopic images. That
means, we want to validate the possibility of using a spectrum of the averaged spatial
information measuring the backscattered signal through an optical fiber. This will modify the
table-top PWS system to a compact real-time diagnosis microscopic system. These changes can
help to develop this system as a commercial product for early, effective, and real-time diagnosis
of cancer or any other abnormalities in cells/tissue for the future.
6.3

IPR study conclusions
We have developed the novel approach based on mesoscopic physics-based light

localization properties, IPR technique to quantify the nano to submicron scale mass density or
refractive index fluctuations in a weakly disordered medium using TEM and Confocal imaging.
The main advantage of the Confocal-IPR technique is that we can probe and quantify a
molecular-specific spatial mass density structural change. In this work, we mainly use the
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Confocal-IPR and TEM-IPR techniques to probe nanoscale mass density fluctuations in the
cells/tissues to study cancer, drug effects, or and brain abnormalities using a mouse model. First,
the confocal-IPR technique was used to study the effect of probiotics in chronic alcoholic brain
cells/components targeting it with different dyes/proteins. Interestingly, the IPR result shows that
the statistical parameter standard deviation of the average IPR, (<IPR(L)>) or the disorder
strength (Ld) increase in chronic alcohol-treated glial cells and chromatin of mice brain tissues
while decreasing gradually when treated with probiotics (L. Plantarum) simultaneously. Here, an
increase in the molecular specific degree of disorder strength (Ld) of chronic alcoholic mice brain
glial cells, and chromatin might be due to the adverse effect of alcohol in brain cells which
initially shows effects on the submicron scale quantified by the Confocal-IPR technique.
Whereas alcoholic brains see an improved cognitive function in the presence of probiotics, L.
Plantarum, which may help in soothing the brain cell’s structure resulting in decreasing the
disorder strength (Ld). In conclusion, the reversible effect of probiotics in alcoholic brain
cells/components could be a useful way to mitigate abnormalities in the brain due to alcohol,
stress, or any other sedative drugs that need to be explored using this molecular specific light
localization technique.
Further, using TEM imaging we can target whole cells or nuclei with ~1nm resolution
which facilitates the real view of the cell structures at the nanoscale which cannot be performed
by a standard optical microscope. Thus, with the TEM-IPR technique, the nanoscale massdensity or refractive index fluctuations in ovarian cancerous cells, as well as anti-cancerous drug
effects on non-tumor forming OV202NTC and tumor forming OV202Sh1 cells, are quantified.
Results show an increase in the standard deviation of mass density fluctuations or
(<IPR(L)>)cells value from non-tumorous NTC to tumorous Sh1 cells while the
101

(<IPR(L)>)cells for two different drugs treated tumorous ovarian cells, Sh1-AACOCF3 and
Sh1-MAFP, reduces from tumorous cells Sh1 nearly the same to the NTC non-tumorous cells.
This quantification of the effectiveness of anti-cancerous drugs in ovarian cancer treatment using
TEM-IPR could enhance better drug treatment modalities at its earliest. Although this study is
based on ovarian cancer, however, the technique can be applied to the different cancerous cells
to quantify the effectiveness of different anti-cancerous drugs in cancer treatment. Also, this
method shows the effectiveness of the developed IPR method at the nanoscale level. Therefore,
the proposed model is completely based on quantitative analysis and could be the most reliable
method to study the drug effect in cancer treatment in the future.
6.4

Future work in IPR and its applications
The proposed novel approach of mesoscopic physics-based molecular specific light

localization technique, IPR, using the TEM and confocal images can quantify the nano to
submicron scale mass density fluctuations and provides numerical means to distinguish cancer,
drug-effect in cancer treatment, or brain abnormalities. The complication in sample preparation
and huge instrumentation setup of TEM which can probe samples up to ~1nm shows a potential
application for the future to quantify the structural properties of different types of cancerous cells
and the efficacy of drug effect in cancer treatment combining with IPR technique. Also, a further
improved molecular mass density specific IPR map with a reduced noise could help us locate the
most affected region in cells with cancer or any other abnormalities. This quantitative IPR
technique will be more useful to the pathologist who uses stained cells/tissues for cancer
screening, grade classification, and study drug-effect visualizing constructed IPR images.
The IPR technique is universal to probe the structural disorder. Initially, it was used for
cancer diagnosis, however, now we have extended and used it to probe brain abnormalities due
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to stress, Alzheimer's, or alcohol using confocal imaging. The novel approach of studying
probiotics' effect in the alcoholic brain where probiotics are used to soothe and increase the
cognitive function of the brain can be quantified using a confocal-IPR technique for different
types of commercially available probiotics to understand their effect on the brain cells/tissues.
This will help to select the right probiotics at their earliest to enhance the cognitive function of
the alcoholic brain before being too late for treatment, at this clinical research moment. Based on
the results obtained for alcoholic brain tissue, we can elaborate our study using the confocal-IPR
technique to study the structural change in brain cells/tissues at the nanoscale level due to stress,
depression, and Alzheimer's in a mouse model. Recently developed super-resolution microscopy
has a significant interest in imaging nanoarchitecture which can reach the sensitivity up to 5 nm.
In the near future, we want to develop an algorithm based on mesoscopic physics-based light
localization technique to quantify the structural properties in cells/tissues using super-resolution
microscopy images and compare the obtained result with the existing TEM-IPR and confocalIPR results. We believe that this might help us to better understand the structural properties in
cells/tissue at the nanoscale level.
In summary, this research presents a key finding that the quantification of spatial
structural disorder of the weakly disordered medium such as cells/tissues based on mesoscopic
light transportation and light localization approaches are a promising technique to characterize
early carcinogenesis, drug-effect, or brain abnormalities. Of course, the main goal of this
research will direct the improvements in these spectroscopic techniques to use them in a clinical
setting in a hospital, and further with large-scale clinical trials. At this point, it demands further
extensive studies in larger sample sizes and clinical trials to achieve the goal of cancer diagnosis
and treatment in the future.
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APPENDIX B
MATLAB CODE FOR CALCULATION OF THE DEGREE OF THE DISORDER
STRENGTH FOR PWS AND IPR TECHNIQUES
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B.1

PWS program to calculate disorder strength (Ld)

clear all
x_max=1460; %maximum pixel cover in x-axis
y_max=1920; %maximum pixel cover in y-axis
fname = 'Name_of_file';
info = imfinfo(fname);
num_images = numel(info);
for k = 1:num_images % total number of wavelength cover
A = imread(fname, k, 'Info', info);
for j=1:y_max
B(1:x_max,j,k)=A(1:x_max,j); % xyz matric with x,y pixel size of
camera and z wavelength
k %[k j] %[k,i,j, A(j,i)];
end
end
for i=1:1460
for j=1:1920
kmin=1;
kmax=150;
xBB=kmin:kmax;
yBB1=BB(i,j,kmin:kmax);
yBB2=squeeze(yBB1);
yBB4=yBB2';
[b,a] = butter(15,0.5); % 6th order polynomial
yBB=filter(b,a,yBB4);
% finally extracted reflection data
yBB=double(yBB4);
pfBB=polyfit(xBB,yBB,3);
yfBB=polyval(pfBB,xBB);
s1=yBB-yfBB;
s_srt=sort(s1);
s_up= mean(s_srt(1:7));
s2=s1+ abs(s_up);
%s2=s1; %
%s2=s1+ pfBB(1) + 0.000001;
%s2=s1./max(s1);
%s2=(smooth(s2))';
BBrms(i,j)=rms(s2);
qmin=kmin+500; % Starting wavelength to cover in nm
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qmax=kmax+500; % Ending wavelength to cover in nm
q=qmin:qmax; %wavelength region covered
kd=(2*pi./q)*1000; % k vector
kd1=floor(length(kd)/2); %mid length of wave vector
kdm=kd(kd1); %mid value of wave vector
n0=1.38; %refractive index

xcr=xcorr(s2);
y_v=log(xcr(150:154)/xcr(150));
x_v=(1:5)*0.01915;
xx_v=x_v.*x_v;
ck=polyfit(xx_v,y_v,1);
CKm(i,j)=ck(2);
% Structural Disorder to be calculated
LD(i,j) = abs(((n0^2)*rms(s2)*ck(2))/((2*kdm^2)));
end
end
%save DU145_t
figure(401)
subplot(2,2,1)
%imagesc(BB(1:690-400,1:250-100,1))
imagesc(BB(:,:,1))
subplot(2,2,2)
imagesc(BBrms)
subplot(2,2,3)
imagesc((CKm))
subplot(2,2,4)
imagesc(LD)
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B.2

IPR program to calculate <IPR> using confocal images

clear all
t=1;
e=1;
m=4; %sample box size
n=m*m;
n_i_max=250; %total # of boxes in row
n_j_max=250; %total # of boxes in column
k=0;
nf=250;
% histogram division
for n_az=1:6
n_ct=0;
if n_az==1
az =imread('name_of_files.tif');
*****************
end
if n_az==2
az =imread('d2a.tif');
%input
*****************
end
if n_az==3
az =imread('d3a.tif');
%input
*****************
end
if n_az==4
az =imread('d4a.tif');
%input
*****************
end
if n_az==5
az =imread('d5a.tif');
%input
*****************
end
if n_az==6
az =imread('d6a.tif');
%input
*****************
end
az = double(az);
az = double(az(1:1000, 1:1000));
h2=az(1:1000,1:1000);
h1=(255-h2);
for n_i=1:n_i_max
for n_j=1:n_j_max

% input
% input
% input

% change the name of the img

% change the name of the img

% change the name of the img

% change the name of the img

% change the name of the img

% change the name of the img

% input
(careful about the color)
% dimension of the image
% input
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[n_az n_ct+1]
k2=0;
for i2=1:m
for j2=1:m
k2=k2+1;
hu(k2)= h1(i2+(n_i-1)*m , j2+(n_j-1)*m);
end
end
hu_sum = sum(hu);
if(hu_sum==0)
hu_sum=1;
end
hu_N = (hu/hu_sum)*1*length(hu);
hu_N=4*hu_N;
% amplification factor
for ii=1:n
d1(ii,ii)=hu_N(ii);
end
for i=1:n
for j=1:n
a(i,j)=0;
end
end %n
for k=1:n
a(k,k)=d1(k,k);
end%if
for k=1:n
if((k-m)>0)
a(k,k-m)=t;
a(k-m,k)=t;
end
if((k+m)<=n)
a(k,k+m)=t;
a(k+m,k)=t;
end
if((k-1)>0)
a(k-1,k)=t;
a(k,k-1)=t;
end
if((k+1)<=n)
a(k+1,k)=t;
a(k,k+1)=t;
end
124

% input

end %k
[v,d]=eig(a);
ipr_egfr(1,1:n) = sum(v.^4);
[n1,x1]=hist(ipr_egfr*n,nf);
%[n2,x2]=hist(ipr_ht29*n,nf);
%[n3,x3]=hist(ipr_csk*n,nf);
n1_s=sum(n1*(x1(4)-x1(3)));
n1=n1/n1_s;
%n2_s=sum(n2*(x2(4)-x2(3)));
%n2=n2/n2_s;
%n3_s=sum(n3*(x3(4)-x3(3)));
%n3=n3/n3_s;
x1av = sum(n1.*x1*(x1(4)-x1(3)));
%x2av = sum(n2.*x2*(x2(4)-x2(3)))
%x3av = sum(n3.*x3*(x3(4)-x3(3)))
%figure(2)
%plot(x1,n1,'-*b')%, x2,n2,'-*m',x3,n3,'-*r')
% axis([ 1.5 5 0 1000])
n_ct=n_ct+1;
d_sline(n_ct)=x1av;
% all ipr values in one array
d_ipr(n_i,n_j)=x1av;
% ipr matrix
[nn,xx]=hist(d_sline,200);
%n_ct
end
end
figure(100+n_az)
subplot(2,2,1)
imagesc(h1);
colormap(gray);
subplot(2,2,2)
imagesc(d_ipr);
colormap(jet);
subplot(2,2,3)
hist(d_sline,200);
subplot(2,2,4)
plot(xx,nn);
if n_az==1
save name_of_files.dat d_sline -ascii
% input saved file
**************************
end
if n_az==2
save d2a.dat d_sline -ascii
% input saved file
**************************
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end
if n_az==3
save d3a.dat d_sline -ascii
% input
**************************
end
if n_az==4
save d4a.dat d_sline -ascii
% input
**************************
end
if n_az==5
save d5a.dat d_sline -ascii
% input
**************************
end
if n_az==6
save d6a.dat d_sline -ascii
% input
**************************
end
figure, imagesc(d_ipr); colormap(jet)
end

B.3

saved file

saved file

saved file

saved file

IPR program to calculate <IPR> using TEM images

clear all
n_sample=1;
m=20; %number of grids
n_ij_max=148; %(1000/40)
n_ct=0;
t=1;
e=1;
n=m*m;
k=0;
nf=250;
%amp=3; %smplificstion modified
for n_az=1:n_sample
if n_az==1
az =imread('name_of_file.tif');
end
% if n_az==2
% az=imread('control_11.tif');
% end
% if n_az==3
% az=imread('control_16.tif');
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% end
% if n_az==4
% az=imread('control_18.tif');
% end
% if n_az==5
% az=imread('5.tif');
% end
az =double(az);
h1=az;
for n_i=1:n_ij_max
for n_j=1:n_ij_max
[n_az n_ct+1]
k2=0;
for i2=1:m
for j2=1:m
k2=k2+1;
hu(k2)= h1(i2+(n_i-1)*m , j2+(n_j-1)*m);
end
end
hu_sum = sum(hu);
if(hu_sum==0)
hu_sum=1
end
hu_N = (hu/hu_sum)*1*length(hu);
for ii=1:n
d1(ii,ii)=hu_N(ii);
end
for i=1:n
for j=1:n
a(i,j)=0;
end
end %n
for k=1:n
a(k,k)=d1(k,k);
%a(k,k)=amp*d1(k,k); % amplification modified
end%if
for k=1:n
if((k-m)>0)
a(k,k-m)=t;
a(k-m,k)=t;
end
if((k+m)<=n)
a(k,k+m)=t;
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a(k+m,k)=t;
end
if((k-1)>0)
a(k-1,k)=t;
a(k,k-1)=t;
end
if((k+1)<=n)
a(k+1,k)=t;
a(k,k+1)=t;
end
end %k
[v,d]=eig(a);
ipr_egfr(n_az,:) = sum(v.^4);
[n1,x1]=hist(ipr_egfr*n,nf);
%[n2,x2]=hist(ipr_ht29*n,nf);
%[n3,x3]=hist(ipr_csk*n,nf);
n1_s=sum(n1*(x1(4)-x1(3)));
n1=n1/n1_s;
%n2_s=sum(n2*(x2(4)-x2(3)));
%n2=n2/n2_s;
x1av = sum(n1.*x1*(x1(4)-x1(3)));
%x2av = sum(n2.*x2*(x2(4)-x2(3)))
n_ct=n_ct+1;
d_sline(n_ct)=x1av;
d_ipr(n_i,n_j)=x1av;
%n_ct
end
end
end
save c1a
save c1a.dat d_sline -ascii
figure(101), hist(d_sline,nf);
figure(102), imagesc(d_ipr);
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